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INTRODUCTION
The published work relative to the phyto­
chemistry of Claviceps purpurea is fairly voluminous.
In recent years, however, no worker has undertaken a 
general chemical analysis of this drug with the view of 
gaining as much general information about it as possible. 
For this reason, it was considered that a summary of the 
literature together with experimental chemical work sup­
plemented by pharmacological studies would be of value. 
Particularly, an effort has been made to confirm Stoll*s 
method of isolating ergotamine from ergot as described 
in British Patent No, 125,396 of the Sandoz Chemical Co.
C O N T E N T S  -
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2. Action of the Constituents 
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a. Straight Uterine Methods 
b# Pressor Methods 
c# Cockfs Comb Method 
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III. EXPERIMENTAL
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1« Ash
a* Total Ash
b. Acid-insoluble Ash 
c* Acid-soluble Ash
d. Qualitative Determination of the Elements
2. Preparation of a Fluidextract
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b. Fatty Oil
3. Extraction of Alkaloids from Crude Drug
a. According to the Stoll Method 
b* According to the Kraft Method
(1) Extraction of Ergotoxine
(2) Extraction of Ergotinine
c . Large Scale Extraction
4, Isolation of Ergochrysin
5, Analysis of Hydro-alcoholic Extract
a* Alkaloidal Potency of "Fluidextract”
b. Activity of 25 per cent Alcoholic Extract
c. Treatment with Lloyd1s Reagent
(1) Comparative Studies
(a) On Guinea Pig Uterus
(b) On Blood Pressure
d. Identification of Potassium and Magnesium 
Phosphates
e# Identification of Glucose
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TABLES
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A CHEMICAL INVESTIGATION OF ERGOT OF RYE
GENERAL
A. ORIGIN OF NAME
The name for the drug ergot of rye, possibly 
better known as simply ergot, is derived from the old 
French word "argot" (■*■). This means both the spur of a 
cock, and smut, so that the fungus may have received its 
name either because it was like the spur of a cock or 
because it was something dirty. Other English names for 
it are spur, cockspur, eockspur rye, spurred or horned 
rye, eared rye, blasted rye, and others. The German 
names are likewise numerous; namely, Afterkorn, Mutterkorn 
Schwarzkorn, Roggenkorn, Habnensporn, Hungerkorn, and so 
on. The French names are also numerous, for example:- 
Bled avorte, bled cornu, clou de sigle, faux seigle, 
mere de seigle, seigle cornu, seigle corrumpu, ergot de 
seigle. The Latin names are perhaps as numerous:- Secale 
luxurians, Bauhin, Secalis mater, Thalius, Secale cornutum 
Baldinger, Secale puerperale, etc., and the Latinized name 
ergota.
Barger^) lists several additional names. Italian: 
Grano allogliato, grano cornuto, grano sprone, grano spe- 
ronato, segala allogliata, segala cornuta, sperone di 
gallo, chiodo segalino. Spanish: Cornezuelo de centeno. 
Portuguese: Cravagem de centeio. Rumanian: Secara cor­
nuta. Danish: Meldr^je. Norwegian: Meldr^ie. Swedish: 
MjCldryga, mjoTdka. Dutch: Moederkoorn. Russian: Sporyni
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5* BOTANY
The French botanist, Tulasne, was the first to 
clear up the botany of ergot^3  ̂ through his paper ”Memorie 
sur L*Ergot des G-lumacees" published in 1853* This work 
was extended and confirmed by Kdhn^V. Kirchhoff^5  ̂ has 
more recently confirmed this work by infection experiments 
with spores and by the cultivation of the fungus on arti­
ficial media.
According to S h a r p e r g o t  was looked upon as a 
rust or mildew as early as the times of Theophrastus of 
Lehos (370 - 285 B^C.)* Sharp states further:nLonicer, 
Thalius, Caspar Bauhin, and John Ray all had some vague 
ideas about its botany. Others held ludicrous views, as, 
for example, Buffon (1707-1788) who said ergot was a collect­
ion of small animals like eels. Vi/'illdenow (1765-1812) in 
his 1 Species Plantarum1, showed that ergot could be produced 
by planting ergot in a rich moist soil. In his experimental 
work, De Candolle went further than Willdenow, for he showed 
that if the dust of ergot was sprinkled on a sound rye plant, 
the disease was produced. Fries regarded ergot as a fungus, 
which replaced the ovary of the rye, and Munchausen held 
much the same views.” Quekett^6) in 1841 was the first to 
publish the results of a detailed study of ergot.
Due to the classical work of Tulasne and some of 
those following him however, there is no longer any doubt 
as to the life cycle of ergot, which is stated briefly as 
follows: The origin of the ergot sclerotium, developed on
3 -
the rye plant, is the fungus Claviceps purpurea which is 
parasitic during moist seasons on the ovary of grains, grasses 
and sedges of certain species. The development has three stages: 
Stage 1. In the spring or early summer the spores of Claviceps 
purpurea are carried by the wind on to the flowers of various 
Graminaceous plants. In the following, the rye plant only, 
is considered: Here the spores germinate and produce colorless
hyphae, which cover the entire young ovary except its apex and 
penetrate the outer part of the pericarp. The covering mate­
rial consists of a soft, white mass which gradually takes the 
place of the ovary and is known as the sphacelia. During this 
period a saccharine secretion, known as "honeydew", is produced 
by the hyphae and at the same time numbers of conidia (repro­
ductive bodies) are formed, thus contributing to the further 
dissemination of the fungus by means of the insects attracted 
to the honeydew.
Stage 2. After the sphacelia has reached its full development 
the sclerotium is gradually produced at its base by the hyphae 
which now form a dense compact mass instead of a loose felt.
The sclerotium grows and finally projects from the ear of rye 
(which has by now ripened), bearing on its apex the remains 
of the felt. In this compact form the fungus passes the winter. 
Stage 5. The ergot falls to the ground and in the following 
spring sprouts into several long stalked globular heads called 
stromata of ascocarps. Each fruiting head or ascocarp has 
imbedded in its surface several flask-shaped cavities,
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ealled perithecia, from the "bases of which several sacs or 
asci develop from the ends of hyphae. Within each ascus are 
developed 8 threadlike spores (ascospores) which, when the 
ascus ruptures are discharged and are carried by the wind to 
the rye flowers which must be open to receive them. In this 
manner the cycle is completed.
C. THERAPEUTICS
S h a r p s t a t e s  that the wise women of the Highlands of 
Scotland employed ergot (of bere or barley probably) from time 
immemorial. According to Fl#ckiger and Hanhury^^ no undoubted 
reference to ergot has as yet been discovered in the writings 
of the classical authors. The first clear account of the thera­
peutic properties of ergot was given in 1582 by Adam Lonicer^^ 
who, in his Kreuterbuch, mentions its value in hastening labor. 
Lonicer!s views seem not to have been generally known for many 
years later.
In 1747 Rathlauw^^, a Dutch accoucheur, employed ergot 
as a means of rapidly ending lingering labor. He kept this drug 
a secret, although he admitted learning of the properties of the 
drug from midwives. It did not take long, however, for others 
to learn of the virtues of the drug. Levret, a Parisian accou­
cheur, and Laehapelle and Dupille^^, Parisian midwives, are said 
to have used ergot and believed in its efficacy. Thirty years 
after RathlauwTs use of ergot, Desgranges^^ of Lyons prescribed 
it with success. The peculiar and important properties of ergot 
were hardly recognized until the beginning of the 19th century,
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when due to the efforts of Stearns^-1*^, in the United States, 
its use quickly spread. In 1807 Dr. Stearns of Albany, New 
York wrote that he had for some time used a "pulvis parturiens", 
which quickly terminated lingering labor. Prescott, Bigelow, 
Chapman, Hosack, and others of his fellow practitioners, were 
not slow to profit by Stearns1 hint, and very soon ergot was 
extensively tried on the American Continent (-*-).
Ergot was admitted for the first time into an official 
publication when it was included among the substances of secon­
dary importance, in the United States Pharmacopoeia of 1820. The 
admission of the drug into the first edition of this publication 
would thus seem to be due in great part at least to the efforts 
of the above-mentioned pioneers of the use of the drug in this 
country. Barger states that^) "the drug was only admitted to 
the Pharmacopoeia of the London College of Physicians in 1836. 
According to the French Codex of 1839 ergot was required to be 
kept in all pharmacies, and Jourdan in his *Pharmacopee univer- 
selle* of 1840 mentions that, besides being official in America, 
England and France, it had been included in the Pharmacopoeias 
of Schleswig-Holstein (Kiel 1831), Turin (1833) and Greece (1837). 
From the date of Stearns* publication it took about 30 years far 
ergot to become thoroughly established in Europe."
D. TOXICOLOGY
According to Barger^11) various authors have attempted 
to show that ergot and ergotism were known to the ancients. This, 
as he shows in the following quotation is open to question, how­
ever. "For an accurate description of undoubted ergotism we cannot
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go back further than the second half of the 16th century, 
the same period which also gave us the first unmistakable 
descriptions of ergot itself.n For a long time, cause and 
effect were not connected and epidemics occurred even as late 
as in the 19th century. Barger states(H) that the first 
undoubted outbreaks of ergotism took place in Germany in 1581, 
1587, and 1596. The last is particularly famous because of 
its accurate description by the Medical Faculty of the Univer­
sity of M a r b u r g p u b l i s h e d  in 1597.
(11)Barger 1 attributed the absence of great epidemics 
after 1777 to the following causes:
(1) Improvements in agriculture.
(2) Introduction of the potato as an article of diet of 
the poor in the North.
(3) Introduction of maize in the South.
To these reasons might be added the improvements
in milling grain which have been developed.
Small epidemics of ergotism, however, occurred during
the 19th century in Russia, Sweden, and Finland. Sporadic cases
also occurred in France and Germany. The last large outbreak cf
(11 )ergotism in the United States occurred in New York in 1825v •
Ehlers^-^) mentions an epidemic at Tomsk, in Siberia, as last 
as 1883. A mild but extensive epidemic of ergotism in England 
was reported within the last 5 years by Morgan^13). The victims 
were immigrants from Central Europe who lived on rye bread.
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The toxicology of ergot is s u m m a r i z e d ^ » (15), (16) 
briefly as follows:
1. Types of Poisoning
a. Acute ergot poisoning
This occurs infrequently; usually in cases of attempted 
abortion. The symptoms are: Collapse, with a weak 
rapid pulse, tingling, itching, and coldness of the 
skin, unquenchable thirst, vomiting and diarrhoea, 
confusion or unconsciousness, hemorrhage from the uterus 
and occasional abortion; sometimes death from respira­
tory paralysis.
b. Chronic poisoning or ergotism
The symptoms of ergotism are of 2 kinds: Those of 
gangrene and those of nervous disorders.
(1) The gangrenous form
Appearance of pustules, due to defective circu­
lation. In more severe cases the extremities 
are affected. The entire member may be affected 
in the gangrene, which has its line of demarca­
tion: the finger, toe, or limb may slough away 
without bleeding.
(2) The spasmodic or neural form
The first symptoms are depression, weakness and 
drowsiness, often with headache and giddiness, 
painful cramps in the limbs and itching with 
pustulation of the skin. In severe cases 
paroxysmal convulsions set in, generally clonic, 
and often epileptiform, but leaving contractures
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in the limbs or, less often, in the trunk 
muscles•
Treatment is hygienic and symptomatic.
E. PHARMACOLOGY
1* Action of the Drug 
a* On the Uterus
According to Meyer and Gottlieb(1*7) preparations 
of ergot along with pituitary extract and quinine, are 
considered the most important practical oxytocics,i.e., 
drugs to stimulate uterine movements. Ergot prepara­
tions stimulate the uterus especially when pregnant.
In labor, the ordinary doses improve the uterine tone, 
and collect small irregular pains into larger effective 
contractions.^®) According to Sollmann^6) small doses 
may inhibit the contractions while excessive doses pro­
duce prolonged tonic contraction. He also states:
,fwhen proper doses are used during labor, with the os 
fully dilated and no obstruction, they tend to hasten 
normal delivery".
Really effective doses are rather dangerous, how­
ever, because the firm contraction may hinder delivery, 
and compress and asphyxiate the fetus. ̂ ®) M c G u i g a n ^ ^ 
states that because of the uncertainty of the drug’s 
action, and because of the possibility of its causing 
prolonged tonic contractions of the uterus, ergot should 
only be used after the uterus has been emptied. It is 
then used in hastening the uterus to contract to its
-9-
normal size and to prevent hemorrhage. Ergot, McG-uigan 
continues, has the disadvantage of producing severe ute­
rine pains and is now much less used than formerly.
(1) Mechanism of Uterine Action
Sollmann^-^ states that this is peripheral since 
it occurs also in the excised uterus.
(2) Relation to Tone and Calcium Salts in Excised Uterus
According to Sollmann^6 ) "Calcium excess, which 
depresses the tone of the virgin guinea pig uterus, 
increases the response to the contractor action of 
ergot". 
k* On Blood Pressure
C u s h n y ^ ^  and Sollmann^6  ̂ both indicate that when an 
ergot preparation (containing the usual proportion of active 
alkaloids and amines) is injected into a vein there occurs 
some fall in blood pressure followed by a rise above normal.
A preparation containing but little of the specific alkaloids 
and a large proportion of histamine would naturally fail to 
increase the blood pressure because histamine dilates the 
capillaries•(14) any case, unless the ergot preparation
be injected into a vein, the blood pressure of man or animals 
will remain practically unchanged*(16)
°* Ergot as G-eneral Styptic
Bush^-1-̂ ) Sollmann(l6) state that ergot has been used
as a general styptic. It is very unlikely that ergot in this 
capacity has any virtue for, as Bush points out, uterine
-10
hemorrhage is checked by ergot because the uterine walls 
are made to so forcibly contract as to compress the leak­
ing blood vessels and sinuses from the outside. Hemorrhages 
elsewhere would have to be checked by the action of ergot 
upon the walls of the blood vessels and since all blood 
vessels of the splanchnic area would be acted upon similarly, 
there would result a general rise in blood pressure which 
would cause an increase in hemorrhage,
d. Cyanosis of the Combs of Fowl
Ergot preparations administered to roosters cause the 
tips of the comb and wattles to become cold and blue. This
effect may be preceded by temporary blanching. According 
/1 1? \to Sollmamv ' this effect is produced by ergotoxine and 
ergotamine. Histamine produces a similar but much prompter 
change, while the tyramine is ineffective.(16)
This reaction of ergot upon the comb and wattles of a 
certain type of rooster is made use of in a method of ergot 
assay described later. 
e * Gangrene Action
If ergot is given repeatedly to roosters, the bluing 
persists in the tips of the comb, and gradually the entire 
comb and wattles are involved. If the doses are continued 
these parts may fall off • A similar gangrene may attack
the legs, tongue or wings. According to C u s h n y ^ ^  the
gangrene of ergot poisoning arises from prolonged constric­
tion of the vessels by the ergotoxine and ergotamine.
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The susceptibility of different animals to the gangrene 
action of ergot varies. (3-6) pigS react by pustular erup­
tions on the skin, and their ears are also particularly 
susceptible. Horses and cattle show similar changes, while 
dogs and rabbits are not affected.(16)
Action on the Alimentary Canal
In brief, Sollmann^6  ̂ describes this as follows: "in­
jection of ergot or its active alkaloids results in marked 
peristalsis throughout the whole alimentary tract. The 
sensitivity to distention is increased as is also the inte­
stinal motor response to vagus stimulation. This produces 
violent diarrhea. The emesis, however, is already largely 
central."
g. Action on the Central Nervous System
Here Sollmann^^) summarizes as follows: The central ner­
vous system is affected both directly and indirectly. Small 
doses may cause medullary stimulation; (vagus slowing; in­
creased respiration; convulsions; etc.); moderate doses in­
crease the flow through the cerebral vessels; large doses of 
ergot cause death by medullary paralysis.
Ergot has a narcotic effect on roosters.
2. Action of the Constituents
The chief active constituents of ergot are the alkaloids 
ergotoxine and ergotamine and the non-specific amines histamine 
and tyramine. The base acetyl choline is also present but in 
negligible quantity. In addition to the above there are two
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other alkaloids present which have a small fraction of the 
activity of ergotoxine and ergotamine; these comparatively 
inactive alkaloids are ergotinine and ergotaminine. A fifth 
alkaloid, psi-ergotinine, is also present, having just recently 
been isolated,
a, Ergotoxine and Ergotamine
These alkaloids are responsible for the characteristic 
action on the cock!s comb and are concerned in the uterine 
and vascular effects.
Both have been shown to possess, for all practical pur-
(19)poses, identical pharmacological action, by Dale and Spiro; 
Burn and Ellis^O) also concluded that the two alkaloids have 
the same activity. Rothlin^l) found that the results of 
his experiments with ergotamine were similar to the results 
of D a l e with ergotoxine. The chief difference found by 
Rothlin was that ergotamine did not paralyze the respira­
tory center to the same extent as ergotoxine. In 1932 Moir(23) 
on the basis of comparative clinical investigations on the 
human uterus, arrived at the same general result as his pre­
decessors did in the laboratory.
Pattee and Nelson found a slight difference between 
the two alkaloids; 0.40 mgm, ergotoxine being equivalent to
0.45 mgm. of ergotamine. These results are substantiated 
by the work of Wokes and C r o c k e r w h o  find "Biologically 
ergotamine appears to possess 0.8-0.9 the activity of ergo­
toxine, whilst ergotinine and ergotaminine possess about 0.1
-13-
this activity", and by the results of Swoap, Cartland 
and H a r t ^ 6) who find that 1 mgm. ergotoxine is equi­
valent to 1*25 mgm. ergotamine. Lozinski, Holden and 
Diver(27) go further and state that 1 mgm. of ergotoxine 
is equivalent to 1.66 mgm. of ergotamine. They also 
suggest this as the reason for discrepancies in cases 
where ergotamine or one of its salts was used as standard 
with the assumption that the strength of the standard was 
equal to a like amount of ergotoxine or a corresponding 
ergotoxine salt.
Rothlin^®) has recently (1933) brought forth evidence 
showing that there are other pharmacological differences 
between the two alkaloids. He states that ergotoxine in­
jected intravenously or subcutaneously into the rabbit in 
suitable doses (0.5 to 1.5 mgm. per Kg.) regularly produces 
characteristic symptoms of excitement and appearance of 
convulsions accompanied by hyperthermia. Ergotamine pro­
duces in the same small doses either hypothermia or no 
change, the stronger doses, by intravenous injection, pro­
duce lesser hyperthermia and stimulation. In still larger 
doses, continues Rothlin, the same symptoms appear as with 
ergotoxine. From his experiments Rothlin concludes that 
on the average, ergotoxine is twice as powerful as ergota­
mine as far as fever-producing and convulsion-producing 
capacity is concerned. Rothlin also shows that orally or 
rectally, results of this type were negative except in 
doses of 10-20 mgm. per Kg.
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b. Ergotinine and Ergotaminine
Both of these alkaloids are weak in their actions. 
Their activity relative to the two potent alkaloids, 
ergotoxine and ergotamine, is given in the table below 
as determined by R o t h l i n j _ n 1 9 2 8. 
c» Psi-Ergotinine
Has only recently been d i s c o v e r e d ( 3 0 )  and its pharma­






























Lowers the blood pressure and powerfully stimulates 
the excised uterus. According to Thompson^S) ̂ hista­
mine is the only non-specific amine in ergot occurring 
in sufficient quantities to cause appreciable pharmaco­
dynamic activity.
e. Tyramine
Has a pressor effect.(33) r^e amount present in 
liquid extracts of ergot is much too small to be of 
practical importance, however.
f. Acetyl-Choline
Lowers the blood pressure.(34) ^his compound is 
also usually present in negligible quantity.
Adminis tr ati on
According to Sollmann^^ the usual dosage is 2 to 5 cc.,
1/2 to 1 drachm of the fluidextract, or the equivalent of the 
solid extract which is eight times as strong. The response 
to ergot is prompt even when taken by mouth. It appears 
within 15 to 30 minutes and lasts about one-half hour.
B u r n ^ ^  states that powdered defatted ergot, enclosed in 
capsules, may also be used medicinally to maintain a concen­
tration of active alkaloid in the circulation during puerperium, 
an initial dose of the alkaloid having been injected under the 
skin after delivery of the placenta.
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C. METHODS OF STANDARDIZATION
1. PHYSICAL
a# Spectrophotometrically (57),(58)
This method is accurate quantitatively only if 
the alkaloid is present as an individual in the pure 
















(4) Kflssner and Wolff ̂ 4^
All of the chemical assay methods determine the phy­
siological potency of ergot in terms of the total alkaloids.
In accordance with these procedures, the drug is usually extracted 
with ether to obtain the alkaloids which are then removed from the 
ether with acid. The oil present in the crude drug usually causes
-17-
trouble some emulsions unless the oil is first removed* The 
slight solubility of the alkaloids in mineral acids further 
complicates matters in some procedures.
In the gravimetric methods there is always the ob­
jection that the crude alkaloids when weighed, still contain
impurities. Since there is no actual way of checking this and 
since the total alkaloids form such a small percentage of the 
drug, it is readily seen that even a very small amount of im­
purity could be responsible for a considerable margin of error.
In the titration of the alkaloids as in the current
German Pharmacopoeial Method, ammonia is preferable to sodium 
carbonate as alkaloidal precipitant because, the deposited soda 
is not always completely washed out, and, in voluminous preci­
pitates especially, traces of soda often remain.(^0)*(41)
Wessel^®^ proposes in this process that the alkaloids 
be weighed, rather than titrated, because the total amount of 
acid used is 0.5 cc. and this gives opportunity for greater un­
avoidable error than by weighing the crude alkaloids as in the 
gravimetric methods.
The nephelometric method(^2) j_s based on the turbidity 
arising from the addition of Mayerfs reagent to the alkaloidal 
salts in 0.5$ tartaric acid solution. The method is said to give 
results agreeing closely with results obtained by the current 
German Pharmacopoeial Method. Only one gram of crude ergot is 
necessary for the evaluation.
The colorimetric method of Smith^^is based on the 
color reaction of Van Urk^®), which In turn is a modification
-18-
of the general Reaction for indole derivatives. Smith*s 
method evidently offers much that has been lacking in the 
way of a chemical test, if one may he permitted to judge by 
the numerous papers of various authors that have appeared con­
cerning it, since the introduction of the method in 1930.
This method, as do all the other chemical methods, estimates 
the potency of the ergot preparation in terms of total alka­
loids .(50) Briefly, Smith's procedure(43) j_s as follows:
"Five cc. of the fluidextract are evaporated on 
the water-bath under a current of air or in vacuo to 
remove the alcohol. Excess heating should be avoided.
The thick, syrupy residue is transferred quantitatively 
with the aid of about 50 cc. H2O to a separatory funnel.
The aqueous suspension is rendered slightly alkaline with 
NH4OH to a distinct blue reaction with litmus. About 2 cc. 
of 1:10 concentrated KE4 OH will generally suffice. The 
solution is then extracted with four successive portions 
of ether, using 40 cc. in the first, 25 cc. in the second 
and 15 to 20 cc. in the third and fourth. The ethers are 
then united, returned to the separatory funnel and washed 
two or three times with 25 cc. HgO and a few drops of NH4OH. 
This treatment removes most of the yellow alkali-soluble 
pigment which is present in greater or less amount in most 
ergots. One or two additional washings with water will 
remove the excess alkali. The washed ether is made up to 
100 cc. and may be kept in this condition, if well stoppered 
and protected from light, for many weeks.
-19-
f,To complete the determination, 50 cc. of the ether 
containing the alkaloids of 2.5 cc. of the fluidextract 
of ergot are extracted in a separatory funnel three times 
with an aqueous solution of one per cent tartaric acid, 
using 10, 10 and 5 cc.,respectively. The acid solution 
is freed from ether by evaporating it on the water-bath 
under the electric fan to about 15 cc* and is made up to 
volume (20 cc.).
llTwo tubes of 1 and 2 cc., respectively, of this 
solution are prepared and to the first 1 cc. H2O added.
To both tubes 1 cc. of M/60 para-dimethyl-amino-benzal- 
dehyde in concentrated H2 SO4 are added. The tubes are all 
exposed to direct sunlight for 30 minutes. They are then 
compared with standards containing 0.06, 0.08 and 0.10 mg. 
of ergotamine tartrate in a colorimeter. From these results 
the number of mg. per cc. of ergot alkaloids can be calcu­
lated.”
This method in slightly modified form was recommended 
to the Pharmacopoeial Revision Committee of Great Britain by its 
Sub-Committee on Ergot and as a result, the modified form became 
official in the 1932 edition of the British Pharmacopoeia. The 
modification which they adopted, insofar as the actual colorime­
tric test is concerned, is one intended to remove the source of 
error which concentrated sulphuric acid introduces; namely, the 
development of excessive heat and subsequent destruction of alka­
loid, that is, unless temperature control is provided.^50^
- 2 0 -
Specifically, M. I* Smith uses 1 cc. of a reagent consisting 
of a 0.25 per cent. W/V solution of p-dimethylaminobenzalde- 
hyde in concentrated sulphuric acid, and 2 cc. of the alkaloidal 
solution. In the British Pharmacopoeial method, however, in 
order to avoid overheating, Smith1s reagent has been diluted 
with an equal volume of water and 2 cc. of reagent is used in 
the test instead of 1 cc. The strength of the alkaloidal solu­
tion has been doubled and 1 cc. is used instead of 2 cc. In 
order to produce the maximum color on exposure to bright light, 
some rise in temperature is necessary, consequently a tempera­
ture of 45°C. was adopted, since it was the amount of heat which 
gave the best results.
The length of time necessary for the production of 
the desired blue-violet color varies, on a bright day, from 
ten minutes to two hours.(51) Thus it can be seen that in 
winter, difficulties would arise when one desired to make cer­
tain that the full color had developed. According to Allport 
and C o c k i n g (  51.), ordinary artificial light is not suited for 
the purpose, but a mercury vapor lamp or a carbon arc is a 
satisfactory source of light.
As a result of their experimental work on the colori­
metric test, however, Allport and Cocking(51) developed a
modification of the British Pharmacopoeial procedure wherein 
light is not necessary for the development of the color. They
accomplish this by making a reagent as follows:”.....0.125 per
cent. W/V of p-dimethyl-amino-benzaldehyde in 65 per cent
-21-
sulphuric acid (V/V) to which 0.1 per cent(V/V)of a 5 per cent 
solution of ferric chloride is added (=0.005 per cent W/V FeC^) . 
Two millilitres of this reagent was added to one millilitre of
the alkaloidal solution...... rt These authors also show that the
presence of as little as 4 parts per million of peroxide in the 
ether causes a decrease of about 5 per cent in the color value. 
Consequently they emphasize the importance of using pure anesthe­
tic ether for the extraction of the alkaloids as specified in 
the British Pharmacopoeia. Allport and Cocking^51) obtain very 
close agreement between results obtained by their modification 
and that of the official method. Others(52),(53),(54),(27), 
have also reported very favorably on this modification. Smelt 
in addition to reporting favorably on the above modification also 
states that the temperature of 45°C., specified in the British 
Pharmacopoeia, is attained on mixing the liquids in the Allport- 
Cocking modification due to the increase in acid strength over 
that in the official process, and thereby requires no additional 
heat. Smelt recommends, however, that 15 minutes be allowed f<r 
the color to reach its maximum instead of one minute as stated 
by the originators of the modification.(51)
In some cases difficulty has been experienced in the 
British Pharmacopoeial assay due to emulsification. To remove 
this difficulty Smelt^52) proceeds as follows:
"Five millilitres of the liquid extract was diluted with 
25 millilitres of distilled water, rendered slightly alkaline 
with about 0.7 millilitre of dilute solution of ammonia, and 
extracted with successive portions of 40, 35, 30, and 30 milli­
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litres of ether. It was found advisable not to shake too 
vigorously during the first extraction with ether, but after 
this the mixtures could be shaken vigorously. The ether 
solution was washed as directed in the British Pharmacopoeia 
and then extracted 5 times with successive portions of 4 milli­
litres (or, for strong extracts, 5 millilitres) of 1 per cent. 
W/V solution of tartaric acid. After removal of the dissolved 
ether, the acid solution was made up to 20 millilitres (or, 
for strong liquid extracts, 25 millilitres)."
Swoap, Cartland, and Hart^®^ make provision against 
emulsification by allowing the alcohol in the original 5 cc. 
of fluidextract to remain. This alcohol, they claim, is of 
advantage in the separation of emulsions.
Stevens(54) uses a Watkins extractor(55) to insure 
against emulsions.
Smelt(52) ptnds that dilution with water and com­
parison in Nessler tubes gives results comparable with those 
obtained by her with a Klett colorimeter. This would tend to 
simplify the apparatus necessary for the test if it is really 
of general application.
Upsher Smithes) recommends the use of a copper 
solution as a"super-standard" in the use of the colorimetric 
test. He uses an ammoniacal cupric sulphate solution contain­
ing 0.67 per cent of chemically pure crystalline cupric sulphate, 
or the equivalent of the dessicated salt, to match a freshly 
prepared solution of ergotoxine ethanesulphonate containing 0.1 
mgm. of anhydrous ergotoxine in 1 cc. He states that the
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similarity in color of the copper solution to that of the 
standard is remarkably close, regardless of whether the British 
Pharmacopoeial or the Allport-Cocking reagent be used. It is 
best, however, to match the colors in daylight "using a Bausch 
and Lomb Duboscq colorimeter" • In a series of experiments Smith/53) 
matches the ergot samples (a) against a freshly prepared British 
Pharmacopoeial (Hereinafter, B.P.) ergotoxine solution treated with 
the B.P. reagent; and (b) against an ammoniacal copper sulphate 
solution containing 0.67 per cent of chemically pure crystalline 
cupric sulphate. In another series of experiments, the B.P, reagent 
was replaced by the Allport-Coeking reagent (which requires no light 
for the development of the color), using the same samples of ergot.
Ihe two sets of experiments show a fairly close agreement and Smith 
suggests that the copper standard may have a useful function in 
that it serves to check the ergotoxine standard against a fixed 
standard , thus guarding against the use of an ergotoxine salt or 
solution that has deteriorated, and it provides an easily obtain­
able check of one's results.
Upsher S m i t h / 53) also tried the use of a 2 per cent 
solution of vanillin in concentrated sulphuric acid (free from 
nitric acid) in place of the B.P. reagent as proposed by Freudweiler156) 
Equimolecular proportions of ergotoxine, ergotamine, and ergotinine 
are stated to give the same degree of c o l o r . S m i t h  found that 
65 per cent V/V sulphuric acid was more favorable because it de­
veloped less heat and with this substitution in Freudweiler1s 
proposed test, Smith obtains results which are in fair agreement
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with results obtained in the B.P* method and the Allport- 
Cocking modification. Upsher Smith states, however, that 
he prefers the Allport-Cocking modification because the 
Freudweiler reagent "produces a color which is hard to match 
in the Duboscq colorimeter, either by daylight or by artifi­
cial light, showing rose red, and lacking the bluish or pur­
plish tint of the ergotoxine solution". Allport and Cocking^51) 
tried the effect of replacing the p-dimethyl-arninobenzaldehyde 
by other aldehydes, and it was observed that a large number of 
these produced a color with ergotoxine in the presence of a 
mineral acid when exposed to bright light. According to their 
observations the color would not develop in any case unless 
exposed to bright light* None of these aldahydes, among which 
were vanillin, piperonal, paraldehyde, benzaldehyde, etc., 
showed any advantage over the p-dimethylaminobenzaldehyde and, 
in fact, many were less sensitive.
In comparing results obtained on testing ergot by the 
Broom-Clark biological method, that is, the Broom-Clark method 
and its various modifications, with results obtained on testing 
the same sample of ergot by Smith1 s colorimetric method and its 
modifications, it is seen that practically all writers have 
reported favorably with respect to the use of the colorimetric 
method and its modifications as quantitative assay procedures. 
For example, the reports of Smith and Stohlman^57)^ Swoap, 
Cartland, and Hart^2^ ,  Stevens and the report of the Ergot
S u b - C o m m i t t e e ^ ) of the British Pharmacopoeial Revision may be 
mentioned.
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The latter report is of particular interest at 
this point. The committee believes from the evidence before 
it that 60 to 70 per cent of the total alkaloids consist 
of the active alkaloid ergotoxine. For this reason the 
committee recommended a total alkaloidal percentage of 0.05 
which corresponds to an ergotoxine percentage of 0.03, the 
desired potency of the official extract as measured by the 
B.P. color test. The actual reasons for the committeefs re­
commendation are readily apparent from the first 4- of their 
conclusions in the summary of their report:
”1. That ergotoxine is to be regarded as the active 
principle for which ergot preparations are administered, 
and that all preparations should be standardized from this 
viewpoint.M
fr2. That the colorimetric method carried out as recom­
mended permits an accurate estimation of total alkaloid in 
ergot and in liquid extract of ergot.n
”3. That the colorimetric method has advantages over gra­
vimetric methods in that smaller amounts of material suffice 
and the assay is more quickly completed.”
”4. That the biological methods are subject to a consi­
derable margin of error and the evidence is that this margin 
is at least as great as that due to the variation in the rela­




Tschlrch^-) v/as the first to propose one of this 
kind. His method proceeds essentially as follows: Extract
1 gram of drug with 20 cc. of ether, 20 cc. of water and 10 
drops of ammonia. After gentle shaking and the elapse of 2 
hours separate the ethereal solution and evaporate. Dissolve 
the residue in glacial acetic acid. Pour under the glacial 
acetic acid some sulphuric acid containing ferric chloride so 
as to form 2 layers. A blue coloration at the junction of the
2 layers shows a minimum of 0.02 per cent alkaloid.
Harmsma(36) reports favorably on this procedure, 
having found it more delicate than Tschirch indicated.
Hering(^5) proposed a somewhat similar method: Prepare 
an infusion from 1 part of ergot powder (defatted) and 20 cc. of 
distilled water to which 1 drop of hydrochloric acid has been 
added. Filter off 4 cc. (= 0.2 g. powdered ergot), treat with 
1 drop of aqueous ammonia and shake strongly with 10 cc. of ether. 
Pipette 5 cc. of the clear supernatant ether into about 3 cc. of 
pure sulphuric acid. This should produce a cornflower-blue color 
at the junction of the 2 layers.
Killssner and Wolff published a volumetric method 
wherein the property of the alkaloids to form difficultly soluble
crystalline salts with picric acid is made use of: Extract 
twenty-five grams of coarsely powdered drug by shaking for 1 hour 
with 120 grams of chloroform in a cork-stoppered 150 cc. flask. 
Filter. Evaporate the chloroform from 60 grams of the filtrate 
by placing on a water bath. Stir constantly. Cool, take up the
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residue in 15 cc. of ether and filter into a glass cylinder 
graduated in tenths of a cubic centimeter. Wash dish and filter 
with sufficient ether to make 24 cc. Then add 1 cc. of a 5 per 
cent solution of picric acid in benzol. This makes a total 
volume of 25 cc. The quantity of precipitate formed is in de­
finite proportion to the amount of alkaloid present. The poten­
cy of the drug is figured on the following basis: 1.6 cc. of
precipitate corresponds approximately to the minimum requirement 
of the German Pharmacopoeia, that is, 1.6 cc. - 0.05/o alkaloids, 
and 2 cc. = 0.06$ etc.
Oettel(^6 ) has proposed the following approximate 
method: Prepare a fluidextract from 5 grams of drug by perco­
lation with 15 to 20 cc. of 50 per cent alcohol. Evaporate the 
liquid extract to 5 cc. below 40°C., and make alkaline with 
about 5 drops of 10 per cent sodium carhonate solution. Shake 
for 10 minutes with 20 cc. of ether. Wash the ethereal liquid 
three times with 10 cc. of water containing 1 drop of 10 per 
cent soda solution. Shake the ethereal solution with 10 cc. 
of 1 per cent tartaric acid solution. Free this of ether and 
treat with the soda solution, drop by drop. A flocc-ulent, white 
precipitate must appear. Filter and take up with 2 cc. of gla­
cial acetic acid. One drop of dilute ferric chloride solution 
is added to the acetic acid solution and to the mixture is added 
2 cc. of sulphuric acid so as to form 2 layers. At the junction 
of the 2 liquids a blue-violet zone appears.
Peyer, Hensel, Jaschik, Breslau and Rosenthal^^ omit 
the T s c h i r c h ^ t e s t  from their comparative study of approximate
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methods of estimation of alkaloidal potency because they consider 
the H e r i n g (45) method an improvement on the Tschirch procedure#
In a series of tests with 20 samples of ergot they compare the 
results of the alkaloidal picrate method, the Hering method and 
the Oettel method with, their results obtained on the same samples 
by the Keller-Fromme method# On the basis of these results they 
conclude as follows:
1 . The alkaloidal picrate method is undesirable because of 
the excessive amount of material necessary and because of its 
lack of concordant results,
2# As approximate methods of assay, they recommend in order
of naming: The Hering test and the Oettel test#
3* For practical purposes the Keller-Fromme method is a
sufficiently accurate quantitative method of estimation.
3# BIOLOGICAL METHODS OF STANDARDIZATION 
a# Straight Uterine Methods(59)
The isolated uterus exhibits pendulum-like movements 
and peristaltic contractions# In Locke1s solution, if 
perfused with oxygen, these movements may be studied for 
hours #
In the straight uterine method of bioassay, the acti­
vity of the ergot preparation is observed directly upon 
the isolated uterine strips of cats or guinea-pigs and the 
resultant effect of the amines and alkaloids is observed; 
the individual constituents of both groups stimulating the 
tissue to contraction. These methods are of no quantitative
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value because they measure the amines more than they measure 
the alkaloids. T h o m p s o n ^ , however, used this type of 
method as a basis in developing a suitable assay for the 
non-specific amine activity of ergot, using uteri of guinea 
pigs taken several weeks post-partem, the animals weighing 
from 500 to 800 Gms. By means of this assay it is possible 
to measure the amine activity of crude ergot and its galeni­
cals, irrespective of the specific alkaloidal content, 
b. Pressor Methods(^1)
The pressor methods measure the resultant effect of all 
the active principles of ergot, and while the pressor reac­
tions produced by the intravenous administration of the 
various constituents are characteristic, the appearance of 
these constituents in mixtures, such as usually exists in 
fluidextracts, practically precludes their application 
quantitatively, 
c • Cock* s Comb Method
According to Gittinger and Munch^62), and Thompson^61) 
it is possible by careful attention to details, to satis­
factorily assay ergot and its preparations by this method. 
This is true because a sample of crude ergot meeting the 
U.S.P. biological requirements always contains at least as 
much alkaloidal activity as is indicated by the cock1s comb 
test, and if interfering quantities of amines are also pre­
sent, the actual alkaloidal content will be greater than 
the amount indicated by the test. Thus even though amines, 
if present in appreciable quantities, do cause a lower appa-
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rent alkaloidal potency in ergot or its preparations, 
they do not entirely destroy the value of the assay, 
d. Vasomotor Reversal Methods
(1) Pressor(35)
This method depends on the antagonistic action, 
on the blood pressure,of epinephrine to the ergot alka­
loids: while the normal epinephrine response is pressor, 
the pressor response after ergot alkaloid administration, 
is either reduced, abolished, or even reversed* The 
end point is the determination of the dose which just 
suffices to produce a reversal or abolition of the or­
dinary pressor effect of epinephrine. The method has 
never gained favor as a routine method of assay because 
of its lack of quantitative sensitivity.
(2) Smooth Muscle
The Broom-Clark^^) Method and its m o d i f i c a t i o n s  ̂>
(24),(63),(64), _ _ _ .. ..also depend on the above mentioned anta­
gonistic action of epinephrine to the ergot alkaloids*
In this instance, however, the test is carried out on 
isolated smooth muscle (rabbit uterus). A similar method 
to this has been proposed by Thompson(60)^ ^n which the 
test is carried out on similar strips of guinea pig uterus 
instead of similar strips of rabbit uterus. Histamine 
replaces epinephrine in this method. ThompsonTs modified 
procedure, however, requires greater skill in manipula­
tion than the method based on the use of the isolated 
rabbit uterus.
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In comparing the accuracy of the rabbit uterus method 
with the accuracy of the cockfs comb method it has been 
generally agreed^59) >(24) ,(63), (32), that the former affords 
somewhat greater precision than the latter, but the former 
is more difficult of technique and therefore requires more 
experience in its use,
U .  CHEMISTRY 
A. History
According to B a r g e r t h e  earliest chemical investi­
gations of ergot, in the eighteenth century, are naturally 
of little interest today since they were undertaken In the 
hope of ascertaining whether the material was a fungus and 
of determining the cause of the toxicity. This was the 
type of investigation carried out by Vauquelin in 1816.
In 1831 W i g g e r s ^ ^  traced the activity of ergot to a 
resin; he also examined the oil and discovered f,cholestrene,r 
and a sugar. By 1869 Ludwig(^7) already distinguished
two sterols, one of which was ergosterol.
In 1864 alkaloids were shown to be present by Wenzell^®). 
Others^9 )* (67), (70), (71), investigated further, but no 
alkaloids were obtained in a state of purity until Tanret(^) 
in 1875, crystallized ergotinine. Tanret thought that he 
had isolated an important active principle. As a matter of 
fact,he did obtain such an active principle from the mother- 
liquors of the crystalline alkaloid, but failed to recognize 
that it was a separate substance, and regarded it merely as
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amorphous ergotinine. Dragendorf and Podwyssotski^^ ,
Jacobj^^ , and other pharmacologists found ergotinine
to be inert. For the recognition of the physiologically 
active alkaloid, however, their chemical methods were 
inadequate. The high molecular weight of this alkaloid, 
its amphoteric properties, and the fact that its salts are 
precipitated by electrolytes, caused it to remain adsorbed 
on acidic substances, which Kobert^^) and Jacobj^-^ 
described as active principles.
These impure preparations, callednactive principles"
owed their activity to a single alkaloid, which was first
isolated in the form of its crystalline salts by Barger
and C a r r ^ ^  in 1906, and was named ergotoxine. Simulta- 
(77)neously Kraftv ' recognized this second alkaloid and showed 
that it could be formed from ergotinine and could be recon­
verted into the latter. He attributed this formation to 
hydration and called it hydro-ergotinine. Barger and Carr^^) 
showed by analysis that the two alkaloids actually differ by 
only a molecule of water.
In 1918, Stoll(78) discovered a third ergot alkaloid, 
ergotamine, which crystallizes readily and has a physiolo­
gical activity like that of ergotoxine. It can be converted 
into an inactive isomeride, ergotaminine. Stollfs new alka­
loids are evidently very closely related to the older ones. 
They occur only in certain specimens of ergot, and it has 
been questioned whether these are of the official variety(^).
-33-
In 1930 Smith and Timmis^^) described the crystalliza­
tion of ergotoxine, and in 1931 they also described a 
fifth alkaloid, psi-ergotinine^50), which has not been 
fully investigated, but which is thought to be an isomer 
of ergotoxine.
Ergot contains a number of simple amines, usually 
formed as a result of bacterial action. It was through 
the Investigation of ergot extracts that the remarkable 
properties of histamine were discovered.(37)
Ergosterol, first accurately studied as a constituent 
of ergot by Tanret^^) in 1889 and 1908, has been found 
widely distributed in nature and has acquired great biolo­
gical importance. Ergothioneine, a base, was found in 
ergot by Tanret^®*^ in 1909.
Finally, it is interesting to note the relationship 
to ergotinine and its hydrate ergotoxine, of some of the 
substances in the drug reported as "active principles" and 
properly classified by Barger and Dale^®^.
Ecboline and ergotinine (Wenzell) = Mixtures of 
alkaloids containing choline (Meulenhoff)•
Amorphous ergotinine (Tanret) » Impure mixture of 
ergotinine and ergotoxine.
Picrosclerotine (Dragendorff) = Ergotinine possibly 
mixed with ergotoxine.
Sclerocrystalline (Podwyssotski) s Ergotinine. 
Sphacelinic Acid (Kobert) •» Inactive resin with 
adherent alkaloid.
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Cornu tine (Kobert) = Impure mixture of ergotinine 
with ergotoxine.
Chrysotoxin (Jacobj) a Inactive yellow coloring matter 
with a small proportion of adherent alkaloid.
Secalintoxin (Jacobj) s Mixture of ergotinine and 
ergotoxine•
Sphacelotoxin (J&cobj) = Impure ergotoxine. 
Hydroergotinin (Kraft) ■ Synonym for ergotoxine.
i. INORGANIC CONSTITUENTS
According to Dieterich^^), fresh ergot contains from
4.4 to 4.8 per cent of water, and on keeping, the amount may 
increase to as much as 10 per cent. The ash content ranges 
from 2.2 to 7 per cent. In an ash analysis by H e r m a n n ), 















The chief constituent of the ash is potassium phosphate, 
KH2PO4 *
2 .  ORGANIC COrlSTITtlENTS 
a. Carbohydrates
(1) Trehalose
According to Barger(2) the characteristic sugar 
of ergot and other fungi is trehalose 
present in variable amounts of the order of 0.1 per 
cent. It was discovered by T/iggers^ in 1831.
M i t s c h e r l i c h ^ ^ )  in one case obtained as much as
2 Gms. from 2 kilos of ergot, some samples of ergot 
however, contained no sugar. This disaccharide does 
not reduce, forms no osazone, and is hydrolyzed to 
2 molecules of glucose. According to Buchheim(^), 
trehalose may decompose producing lactic acid, in 
the. process of its decomposition. This would account 
for the acid reaction and small sugar content of some 
ergots•
(2 ) Mannitol
This polyhydroxyl compound was found in ergot by 
Ludwig(^7) an£ by iater investigators such as Kraft(^7) . 
It has the formula CgH^Og and its melting point is 
166°.
(3) Clavicepsin
This glucoside was discovered in ergot by Marino 
Zuco and Pasquero^^) # They used 95 per cent alcohol 
as their menstruum and by refluxing continually for
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6 to 7 days, obtained yields which varied from
1.5 to 2 per cent. This compound is very soluble 
ih water, slightly soluble in alcohol, and easily 
undergoes hydrolysis as follows:
g18h 34°16 + 2h2° - 2G6H12°6 + C6H14°6
One molecule of clavicepsin produces 2 molecules of
glucose and one molecule of mannitol. The hydrated
compound melts at 91°; the anhydrous compound melts
at 198°. Clavicepsin is strongly dextrorotatory:
20°
J  = + 142.27°
D
(4) Mannan
This polysaccharide was obtained from ergot by 
Voswinkel^8) in 1891. On hydrolysis it produces 
mannose. Voswinkel first obtained it as a brown, 
amorphous, hygroscopic mass, 
b • Coloring Principles
(1) Sclererythrin
This reddish-violet substance was first investi­
gated by Dragendorf and P o d y s s o t s k i w h o  gave it 
the above name. It is soluble in alcohol, alkalies, 
and in ether which contains sulphuric acid. 'The deli­
cate chemical detection of ergot in flour is based on 
the recognition of this principle when extracted from 
the flour^^). The characteristic absorption spectrum
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of sclererythrin has also been frequently used for 
the detection of ergot(90) 9̂ -) .
(2) Ergo chry s in
This yellow principle, according to Barger^^, 
was first accurately analyzed by Jacobj^4 ), who 
assigned it the formula C2]H22°9* Ergochrysin, states 
Barger, is identical with the secalonic acid of Kraft 
since the analyses fit the above formula almost as well 
as the one, assigned by Kraft himself* The
substance forms lemon yellow needles which melt at 
244°C. It is insoluble in water or gasoline, and 
slightly soluble in carbon disulphide, carbon tetra­
chloride, methyl alcohol, and ether* It is soluble 
in 160 parts of boiling alcohol, 200 parts of cold 
alcohol, 100 parts of boiling benzene and in 50 parts 
of boiling glacial acetic acid^2 ). The alcoholic solu­
tion produces a reddish-brown color when treated with 
ferric chloride.
Kraft assigned his secalonic acid the formula
C14H14O6 which agreed very closely with his analyses.
He adopted this formula, however, without benefit of
(92)molecular weight determinations. Recently Bergmann' ; 
determined the molecular weight of the substance as 
556-557 and assigned it the formula CgQH28°12 on the 
basis of his analyses. Bergmann found the melting point 
of the yellow leaflets, crystallized from chloroform,
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to be 266°. On recrystallizing from a hot pyridine 
solution, containing alcohol, golden yellow needles 
were produced, having a melting point almost the same 
as Kraft’s secalonic acid, that is, 242° to 244°. The 
composition of the latter appears to be c28H12°12*1/2H20  ̂
however. According to Bergmann, boiling acetic anhy­
dride produces about 10 per cent of a decaacetate,
M.P. 240°. Methylation experiments producedno cry­
stalline products.
(3) Ergoflavin
This yellow pigment, was found by
F r e e b o r n ( 9 3 ) , wfr0 separated ergoflavin from an eva­
porated ether extract of crude alkaloids, by means 
of sodium carbonate solution. Ergoflavin differs 
from ergochrysin in its melting point (338°), by its 
behavior to alkalies, and by its composition and mole­
cular weight. By fusion with potash at 320° a volatile 
fatty acid is formed • Dilute sodium hydroxide con­
verts the substance into a colorless hydrate from which 
the anhydride is easily regenerated.
Bergmann(^2) confirmed the formula for ergoflavin 
as given by Freeborn but assigned it a melting point 
of 344°. With acetic anhydride and a drop of concen­
trated sulphuric acid, Freeborn obtained the tetra­
acetate of a substance containing 1 molecule less of 
water than ergoflavin. Bergmann, however, both with
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acetic anhydride in cold pyridine and with boiling 
acetic anhydride, always obtained a pentaacetate•
He confirmed the pentaacetate by showing the presence 
of 5 hydroxyl groups according to his Zerevitinov 
determinations. By boiling a few minutes in dilute 
alcohol or alcoholic potassium hydroxide an orange 
colored solution was produced which was decolorized 
by acids with formation of a crystalline monobasic 
ergoflavonic acid, M • P * above 330°, An aqueoiis solu­
tion of this acid soon became yellow, when boiled, 
and regenerated ergoflavin. This points to the presence 
of a lactone group and thus the 7 oxygen atoms would be 
accounted for* Bergmann has stated further that when 
ergoflavin was fused with potash the following products 
were obtained: (C00H)2, GH3C00H, 3,5-Me(H0)C6H 3C00H, 
and a mixture of about 1 part m-CgH^COHjg and 10 parts 
[2,4(0H)2C 6H 3 ] 2 * Y/ith a large excess of nitric acid 
at room temperature, ergoflavin yielded a compound of 
the formula M*P* 260°.
c* Glycerides and Sterols
Many of the earlier investigators knew of the large 
quantity of fatty oil present in ergot. Thus Herrmann(84)} 
Ludwig(67)^ an(̂  Granser^*0 some work on the oil around
1870. More recently the oil has been examined by MjCten^^ 
R a t h j e ^ ^ ,  Zellner^^, Dieterle, Diester and Thimann^*^,
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Mat the s and Schutz^98), Baughman and Jamieson^"), 
and by Fiero^100). The composition of the oil as 
well as the yield obtained depends upon the manner of 
its extraction: with gasoline Mjfcfen obtained 21 per 
cent, as did also Zellner; Rathje extracted with ether, 
and Dieterle, Diester and Thimann expressed the oil. 
According to B a r g e r t h e  density at 20° varies from 
0,9170 to 0.9259; the refractive index at 20° varies 
from 1,4685 to 1.4739; the amount of non-saponifiable 
matter varies from 0.35 to 1.037 per cent. Matthes 
and Schutz state that the oil is dextrorotatory, 10.5° 
to 10.7°, which is due to the hydroxy oleic acid present. 













Saponification 196.9 195.4 193 179.3 178.4
Iodine (of oil) 73.8 66.6-70.1 69.55 74.0 71.08
Iodine (of acids) 101.2 --- --- --- 75.09
Reichert-Meissel 0.3 --- 0.47 0.63 0.20
Hehner --- 96 96.1 96.25 96.3
Acid --- --- 13.19 11.38 4.95
Acetyl (of oil) 7.3 --- 60.4 29.12 62.5
Acetyl (of acids) --- 73 --- 77 75.1
TABLE IV
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The Iodine number shows that the oil belongs in the 
non-drying class• The Reichert-Meissel number indicates 
the presence of about 1 per cent of volatile fatty acid. 
The Hehner number is the percentage of insoluble fatty 
acids obtained. The acid number given above corresponds 
to about 6 per cent of free fatty acid, but, according to 
B a r g e r , fresh ergot oil may have as little as one-sixth 
this amount. The high acetyl number indicates the pre­
sence of some hydroxy acid. Matthes and Schfttz^98) did 
obtain a large quantity of hydroxy-oleic acid, which is a 
characteristic constituent of the oil* The distribution 
of the fatty acids, according to Matthes and SchEltz^98^, 









Palmitic About 28% 21.5# 25#
Hydroxy Oleic 36% --- ---
Oleic 32*4:% 62.5# 20.5#
Linoleic 3.6% 8 . 77# 13.2#
Myristic --- 0.3# 3.#
Stearic --- 5.3# 2 .1#
Arachic --- 0.7# ---
Ricinoleic --- --- 35.8#
Linolenic --- --- Traces
TABLE V
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The non-saponifiable portion of the oil contains 
characteristic sterols. Ludwig^67), in 1869, found two 
varieties, one melting at 141° and the other at 160°. 
Tanret^80 ,̂ in a later study of these,named the higher 
melting sterol, present in much larger amount, ergosterol, 
C27H4 1OH.H2O. It crystallizes from alcohol and from ether, 
M.P. Ib2 * Tanret named the lower melting sterol, fungi- 
sterol, Cg^HggOH.HgO, M.P. 144°. Both sterols are purified 
by means of their respective acetyl derivatives. With 90% 
sulphuric acid the two sterols are easily differentiated; 
fungisterol yields a ruby red color in about 10 seconds; 
ergosterol yields a dirty red color at the end of one 
minute.
Ergosterol is the more important of the 2 sterols 
because of the fact that on Irradiation It yields vitamin D. 
This has brought it into great prominence and has led to 
the investigation of its adsorption spectrum, constitution 
and derivatives. The amount of ergosterol present in ergot 
is about 0.1 per c e n t . ^ ^ * ^ ^
d. Enzymes
According to S c h i n d e l m e i s e r e r g o t  contains at 
least two enzymes, one possessing diastatic, and the other 
fat-splitting properties. These enzymes lose their acti­
vity on prolonged standing or drying of the ergot.
(1) Diastatic
This activity was demonstrated by stirring fresh 
coarsely powdered ergot to a paste, addition of some
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toluene-chloroform mixture as preservative, and 
shaking for 6 hours. The aqueous extract was 
separated and treated with 3 volumes of 90% alcohol.
The precipitate was washed and 5 gms, of it was 
suspended in 200 gms, of 1% starch solution with pre­
servative added. This was allowed to stand at 35° 
for 6 days. The contents were then boiled and fil­
tered. A test for starch, with iodine solution, was 
negative. Schindelmeiser isolated glucose and maltose, 
as the respective osazones, proving the ability of 
the enzyme as a diastatic agent,
(2) Pat-Splitting
This activity was not shown as definitely as 
was the diastatic activity. To demonstrate this, 
Schindelmeiser in one experiment treated 5 gms. of 
non-defatted ergot powder with 20 gms. of olive oil. 
This mixture was allowed to stand for 12 days at 18-20° 
with daylight excluded. Ten gms. of the oil dissolved 
in ether-alcohol was titrated with tenth-normal alco­
holic potassium hydroxide solution, using phenolphtha- 
lein as indicator. Thus the amount of fatty acid split 
off by the enzyme was estimated. The results were then 
calculated for 20 gms. of oil and were compared with 
the results obtained in like manner using defatted 
ergot. The difference, as Schindelmeiser pointed out 
was not very significant. For example, he obtained 
for the non-defatted ergot an amount of fatty acid
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equivalent to: 6.3 cc., 7.8 cc., and 6.1 cc. n/10 
alcoholic KOH. For the defatted ergot he found:
4.6 cc., 5.6 cc., and 4.9 cc. Schindelmeiser sug­
gested that the fat-splitting enzyme was either dis­
solved in the oil or was in chemical combination with 
it.
e. Acids~— — —  n
(1) Lactic Acid. CI^ C COOH.
0 H
According to B u c h h e i m ^ ^  this acid was found 
in ergot as a fermentation product of trehalose.
(2) Sticcinic Acid. CH^COOH
C H g C O O H
Engeland and Kutscher^^) found succinic acid 
in ergot. According to them it is derived from 
aspartic acid.
(3) Secale Amino Sulphonic.
K r a f t f o u n d  this compound, CigHgsOisfBHgHSOaH), 
M.P. 200°, and named it. In the isolation of the acid 
Kraft proceeded as follows: I-Ie exhausted the drug
with chloroform and subsequently extracted with water. 
He then added an excess of basic lead acetate, freed 
the filtrate of excess lead, concentrated, and pre­
cipitated with potassium bismuth iodide. This pro­
duced a crystalline red precipitate which was decom­
posed with silver carbonate. The filtrate was acidu­
lated with hydrochloric acid and evaporated over
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sulphur ic acid# Prom this, betaine chloride cry­
stallized# The remaining liquid was evaporated to 
dryness and extracted with absolute alcohol# On 
standing, the colorless crystals of secale amino 
sulphonic acid separated out# These were insoluble 
in absolute alcohol# The substance may be recry­
stallized either from dilute alcohol or from a small 
amount of water#
(4) Amino Acids
Leucine, alpha-amino alpha-isobutyl acetic acid,
(CH^JgCHGHgCH NHgCOOH, was discovered in ergot by 
B u c h h e i m ^ ^ . Later, V a h l e n ^ ^ ^  discovered clavin, 
an "active principle" of the formula C-^HggO^Ng.
A molecular weight determination, however, did not
(104)support the above formula# Finally Vanslyke' * 
separated Clavin into 39 per cent# leucine, 22 per 
cent isoleucine, which is ethyl methyl alpha-amino 
propionic acid, £2S 5 >  CHCHHH2 C00H, and 37 per cent
o h 3
valine, isopropyl alpha-amino acetic acid*
CHCHNHgCOOH# Frlnkel and Rainer^105  ̂ obtained a
small quantity of crystalline tyrosine, which is beta-
para-hydroxyphenyl, alpha-amino propionic acid,
H H 
C — C
H0-C/ " 'C-CHgCHWHg CO OH,
*C - G"
H H




imidazole propionic acid HC* II
'N-G-CEoCHNHpCOOH.
According to Holtz and Mdller^9^ ,  the ergot fungus 
must form the amino acids from the rye protein since 
neither amino acids nor amines are contained as such 
in the rye grains.
Amines
(1) Trimethyl amine, (CHg)gN, was found by W a l z ^ ^ ^  
in 1852. It was shown to be derived from choline 
by Brieger^10^  in 1887.
(2 ) Putreseine, which is tetramethylenediamine,
NHg•CHg•CHg•CHg•CHg*NHg, was found by Rielander(109) 
in 1908.
(3) Cadaverine, which is pentamethylenediamine, 
NH2.CH2.CH2.CH2.CH2.CH2. ^ 2  was a-*-s0 f°un<3- hy 
Rielander ̂  ̂•
(4) Isoamylamine, (CHgJgCHCHgCHgNHg, which is present
f 31 )in traces, was found by Barger and DaleWJ-/.
(5) Tyramine, p-hydroxyphenylethy1 amine,
H H 
C — C
HOC* C - CHgCHpNHg, was discovered by
'C = C '
H H
Barger and Dale^*^^ in 1909.
(6 ) Histamine, beta-Iminazolylethylamine,
N - C - ch2ch2hh2 
HC^ 11 was discovered by
XN - C
H H
Barger and Dale^*^ in 1910.
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(7) Agmatine5 guanidobutylamine, H2H-C - N-(CHg)gCH2NH2 , 
was found by Engeland and Kutscher^102) in 1 9 1 0 .
Thus it is seen that six amines have been obtained 
from ergot# According to B a r g e r t h e s e  amines are formed 
from certain amino acids (leucine, tyrosine, histidine, 
lysine, and arginine) by decarboxylation, which is normally 
the result of bacterial action,
g. Additional Simple Bases
(1) Choline, trimethyl hydroxy ethyl ammonium hydroxide, 
(CHg)g - CHgCHgOH, was isolated from ergot by
OH
Brieger * (77) 1 3 3 5 .
(2) Acetyl-choline, (CHg)gsN - CHgCHgOOC CHg, was isolated
OH
(111)in the form of a platinum salt by Ewins in 1914*
The correct formula for this compound was shown by 
D u d l e y i n  1929.
(3) Betaine, the anhydride of trimethyl amino-acetic acid,
(CHg)g i N^^CHgC ss 0, was isolated by K r a f t i n  1906.
(4) Ergothioneine, the betaine of 2-thiol histidine,
H
- CH (CH3& K -  0 , y
HSC M I I was isolated by Tanret' '
- C - CH., CH.CO
in 1909. To prepare this base the ergot was extracted
with 90 per cent alcohol and after evaporation of the
alcohol, the residue was filtered free of fat a n d  resin.
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Twenty per cent sulphuric acid was used to precipitate 
the coloring principles. The acid was neutralized with 
barium hydroxide solution and the filtrate was treated 
with basic lead acetate* After the resulting preci­
pitate was removed by filtration, the excess lead was 
precipitated with sulphuric acid, the solution was made 
alkaline and was then extracted with chloroform to 
remove the ergot alkaloids* The solution was next aci­
dified with acetic acid and treated with a warm 8 per 
cent solution of mercuric chloride* The mercury pre­
cipitate was filtered off, washed, suspended in a large 
volume of water and decomposed with hydrogen sulphide. 
After the mercuric sulphide was removed, the filtrate 
was evaporated, under reduced pressure, to a syrup. 
Prom this syrup ergothioneine chloride readily crysta­
llizes, usually in a yield of about 0,1 per cent. The 
base was obtained by boiling the chloride with excess 
calcium carbonate* This was filtered, concentrated 
and treated with alcohol* The base may be recrystal­
lized from boiling 60 per cent alcohol.
The base crystallizes in leaflets or in needles 
having the formula CgH^gOgl^S.SB^O, It is soluble in 
8*6 parts of water at 20° and in about 1000 parts of 
boiling alcohol; it is insoluble in ether, chloroform
or benzene, - 110°; M.P. 290°.
D
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Ergothioneine has acquired considerable biochemical 
importance because it occurs in mammalian blood corpuscles 
and has reducing p r o p e r t i e s ^ .
(5) Uracilj 2, 6 dioxy pyrimidine, HH - C = 0, was isolated
from ergot by Rielander.(109) 0C GH
I IIHN - CH
(6 ) Guano sine or Vernine, is a compound composed of a molecule 
of pentose with a molecule of guanine:
0= C - NH
H I \
H H H H H N - C ■ C = NH
H O - C - C - C - C - C - C '  II I
H 0 OH OH I *N - C - NH
I— .  I
It was isolated from ergot by Schulze and Bosshard^11^  . 
Vernine is hydrolyzed to guanine and d-ribose:
CioHi305N5 + H20 s C5H5ON5 + C5H1 0 05
h. Alkaloids
According to the literature up to the present time, 
ergot contains five well defined alkaloids: ergotoxine , 
ergotinine , psi-ergotinine , ergotamine, and ergota- 
minine^*7^  •
Barger and Ewins^11^) have shown that ergotoxine and 
ergotinine stand in the same relationship to each other as 
an acid does to its lactone or lactam ; in other words, 
ergotinine (C35H 39O5N5 )is the anhydride of ergotoxine 
(G^^P^pOgNg). The anhydride may be formed by boiling a 
concentrated solution of ergotoxine in methyl alcohol^177̂ 
or by boiling the ergotoxine with acetic anhydride for a few 
seconds.^76  ̂ Conversely, ergotoxine may be prepared from
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ergotinine by the use of4 3 per cent acetic acid or by 
the use of diluted phosphoric acid in alcohol. In 
accordance with' the view that it contains a carboxyl group, 
ergotoxine is soluble in alkali; ergotinine is insoluble 
in alkali and this difference has been used as a means of 
separating the two. Psi-ergotinine is isomeric with ergo­
toxine (30) and is converted into ergotinine in the same 
manner as is ergotoxine, that is, by boiling with methyl 
alcohol. Psi-ergotinine may be converted into ergotoxine 
by boiling with alcohol and phosphoric acid.
Ergotoxine is easily soluble in alcohol and somewhat 
more difficultly soluble in ether. The alkaloid may be 
crystallized from hot benzene, yielding prisms containing
20 per cent of benzene(H 6 ). jn q.6/o chloroformic solution
20°
the crystals give s: -156°. For the solvent-free
5461
20°
base in 0.6$> chloroform solution, = -195°.
5461
The alkaloid may also be crystallized from toluene, xylene 
or mesitylene. Ergotoxine is sparingly soluble in carbon 
disulphide and separates in prisms on spontaneous evapora­
tion of the solvent. When an acetone solution is mixed 
with water, the base is precipitated in the amorphous state.
It softens at 180° and melts indefinitely between 190 to 200°. 
Ergotinine forms needle-like crystals, LI.P. 219°, from
alcohol, - +338° in alcohol. B a r g e r g i v e s  the
D
following solubilities: At 15° it dissolves in about 400 
parts by weight of ethyl alcohol, 1000 parts of dry ether,
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90 parts of ethyl acetate, and 25 parts of acetone. In 
boiling solvents it is soluble in 77 parts of benzene,
52 parts of ethyl alcohol, and in 56 parts of methyl al­
cohol. It is very soluble in cold chloroform, moderately 
soluble in amyl alcohol and insoluble in petroleum ether.
The salts of this alkaloid are amorphous.
Psi-ergotinine was obtained from crude ergotinine by 
fractional crystallization from dilute acetone. It was 
purified by solution in chloroform and fractional precipi­
tation with ether, = +459°(chloroform). The
5461
relative proportions of ergotinine and psi-ergotinine vary 
in different specimens of ergot, some specimens containing 
mainly ergotinine and others mainly psi-ergotinine as the 
subsidiary alkaloid, ergotoxine being invariably the pre­
dominant a l k a l o i d .
Ergotamine and Ergotaminine. These two isomeric alka­
loids, C33H 35O5N5 , were isolated by Stoll in 1921. Accord­
ing to Smith and Timmis^^) they do not occur in all kinds 
of ergots.
Ergotamine crystallizes from aqueous acetone in plates, 
C33H35°5N5»2H20 *2C3H 6°> decomposing at 180°. = +40°
in alcohol. Smith and Tirnmis(179), found that the dry alka­
loid placed in a bath at 205° and slowly heated, decomposes 
at 213 to 214°, corrected. This alkaloid crystallizes from 
the following, containing solvents of crystallization: 
methyl alcohol (pyramids), ethyl alcohol (needles) and
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benzene (prisms). Ergotamine resembles ergotoxine in
that it is a weak monacid base, the salts, however, are
generally more soluble in water than those of ergotoxine( .
Ergotaminine, according to Stoll is isomeric with
ergotamine. Smith and Timmis^79) found its melting point
(corrected) to be 252° when placed in a bath at 240° and
20°
slowly heated. a +381° in chloroform. It cry-
D
stallizes from alcohol in the form of plates resembling 
isoceles triangles. Ergotaminine is readily soluble in 
pyridine and glacial acetic acid. This alkaloid forms no 
crystalline salts and in this respect resembles ergotinine. 
The methods of Interconversion that apply to ergotoxine 
and ergotinine apply also to ergotamine and ergotaminine^79  ̂.
(1) Constitution of the Alkaloids
According to B a r g e r t h e  price of these alkaloids 
and their high molecular weight make the investigation 
of their constitution very difficult. At the present 
time, little is known of the constitution of the alka­
loids since comparatively few degradation products have 
been obtained. In 1910, Barger and Ewins^-^) obtained 
isobutyrul forrnarnide by the thermal decomposition of 
ergotoxine and ergotinine. Recently (1932), Soltys^ 
obtained ammonia by the action of alcoholic sodium hy­
droxide, benzoic acid by oxidation with permanganate, 
and p-nitrobenzoic acid by treatment of these two alka­
loids with nitric acid. Soltys further found that ergo­
toxine and ergotinine both contain 4 replaceable hydrogen
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atoms since on warming with 4 equivalents of* methyl magne­
sium iodide, both alkaloids react.
In 1932,Smith and T i m m i s ^ ^ )  obtained a new base, 
ergine from each of the alkaloids ergotoxine,
ergotinine, ergotamine and ergotaminine. This base is 
crystalline and gives crystalline salts. From its formula 
the base can be seen to approximate roughly one-half of 
the alkaloidal molecule. Accordingly it was concluded that 
ergotoxine and ergotamine are similar with respect to this 
portion of the molecule. Ergine was obtained from the alka­
loids by treatment with normal methyl alcoholic KOH in an 
atmosphere of nitrogen. The base contains one methylimino 
group. The compound crystallizes in colorless prisms from 
methyl alcohol with 1 molecule of solvent, decomposing at 
135°. It also crystallizes readily from aqueous acetone 
in plates which decompose at 115°. Ergine is soluble in 
acetone, chloroform and ethyl acetate and has an optical 
rotation in aceton© solution as follows:
20° 20°
[cxj = 514°; p<] ~ 432°. In chloro-
Hg-green Hg-yellow
20° 20°
form solution: = 598°; fcxj - 503 .
Hg-green Hg-yellow
The base resembles its parent alkaloids in giving the M. I.
S m i t h ^ 3) color reaction.
Jacobs and C r a i g h a v e  recently published (1934), 
an account of a new degradation product (lysergic acid) 
obtained by them from crystalline ergotinine. They dissolved
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the alkaloid in normal methyl alcoholic potassium hydro­
xide solution and removed the methyl alcohol at once by 
distillation under reduced pressure* The residue was 
treated with 8 per cent aqueous solution of potassium 
hydroxide on the steam hath for one hour* Basic volatile 
material was collected by means of a stream of nitrogen 
which passed through the reaction-flask into a solution 
of dilute hydrochloric acid. Ammonium chloride was thus 
obtained by cleavage of the amide groiip of ergotinine*
Jacobs and Craig have assigned the formula CqgHqgOgNg to 
the new compound on the basis of their analytical data 
obtained from their investigation of the acid and its 
methyl ester. Lysergic acid, although sparingly soluble 
in water, is best recrystallized from water. The crystals 
separate with approximately 1 molecule of solvent which is 
held very tenaciOLisly • The crystalline leaflets melt with
-7  2 0decomposition at 238°. = 40° (C = 0.500 in pyridine).
D
This compound gives the characteristic blue Keller test^^ 
of the ergot alkaloids as follows: The alkaloid dissolved
in 2 or 3 cc. of glacial acetic acid is treated v/ith a trace 
of ferric chloride, after which concentrated sulphuric acid 
is poured underneath, without mixing. At the junction of 
the two layers an intense cornflower blue appears at once; 
after a time the glacial acetic acid becomes violet, and 
the upper layers of the sulphuric acid, green. Lysergic 
acid behaves both as an acid and as a base. It is soluble 
in sodium hydroxide, ammonium hydroxide, sodium carbonate,
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and hydrochloric acid* It is slightly soluble In dilute 
sulphuric acid and Is sparingly soluble in the usual neu­
tral organic solvents; it is quite soluble in pyridine*
On titration with alkali, using phenolphthalein as indi­
cator, lysergic acid does not give a sharp endpoint.
(2) Salts of the Alkaloids
Ergotinine and ergotaminine do not form crystalline 
salts. Many crystalline salts of ergotoxine and a lesser 
number for ergotamine have been reported*
(a) Ergotoxine methane sulphonate (120)>C35H41°6H5-CH3S03H - 
2CgHgOH, M*P. 214° (corr*), crystallizes from alcohol in 
clusters of needles,
(b) Ergotoxine ethane sulphonate (120)JC35H41°6N5-C2H 5S03H - 
2 C2H 5OH, M*P* 209° (corr.) crystallizes in the same manner 
as does the methane sulphonate. Both are formed by dis­
solving the base and acid together in alcohol and precipi­
tation of the salts by cooling or by adding ether.
(c) Ergotoxine phosphate^ ^  , C35H43_OgN5 .H3PO4 .H2O, *
M.P* 186-187°, crystallizes from 50 parts of boiling 90 per 
cent alcohol in clusters of radiating needles.
(d) Ergotoxine h y d r o c h l o r i d e ), C^gH^OgNg.HCl, M.P* 205°, 
forms small diamond-shaped plates. It is crystallized by 
dissolving in 15 parts of warm 90 per cent alcohol and slowly 
adding ether*
(e) Ergotoxine hydrobromide^ ^ , C^gH^OgNg.HBR, M*P* 208°, 
forms acicular prisms*
(f) Ergotoxine s u l p h a t e ^ * ^ , ( was 
obtained by Kraft, and forms small crystals.
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(g) Ergotoxine acid sulphate^115^. G35E4i°6N5 -H2s04 >
M.P. 197°, forms prisms*
(£l) Ergotoxine nitrate 1̂15). C35H4i°6N5 •HN03  ̂ M -p - 1Qr7°> 
forms short broad prisms.
(i) Ergotoxine picrate^115V, G35H 410 6N5 .C6H307N3,
M.P. 214 to 215^, pale yellow needles.
(j) Ergotoxine oxalate ̂ 76> (C35H41°6N5)2 *h 2g204 *
M.P. 179°, from oxalic acid and excess of the base 
in ethereal solution.
(k) Ergotoxine acid o x a l a t e  ̂ OflNfi.HpCpOa,
M.P. 179°, is formed by shaking a sortition of ergo­
toxine in xylene with excess of one per cent oxalic 
acid. Small prisms crystallize from alcohol con­
taining acetone.
(1) Salts of ergotamine
The sulphate, tartrate, phosphate, and normal 
oxalate are known. The salts of this base are,in 
general, more soluble in water than those of ergo­
toxine. Possibly the most widely used ergotamine 
salt is the tartrate, known commercially as f,gynerginn 
and "femergin". Ergotamine does not form an acid 
oxalate but ergotoxine does.
The normal ergotamine oxalate is formed 
by using excess oxalic acid.
-57-
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The following constants have recently been redeter1 
mined by Smith and Timmis^79)>(3°):
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(c = 0.35) * (c = 0.15)
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THE MELTING POINTS OF THE ALKALOIDS ARE AS FOLLOWS:






239° (Smith & Timrnis)
Indefinite (190-200°)
213-214° (Smith & Timrnis) 
252° (Smith & Timrnis)
TABLE VIII
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(3) Methods of Alkalojdal Extraction
Tanret^^), the first to isolate a pure ergot 
alkaloid, extracted the drug with 96 per cent alcohol, 
added enough ■ sodium hydroxide to make alkaline, distilled 
off the alcohol and extracted the residue with ether.
This solution was extracted with citric acid, the acid 
solution washed with ether, made alkaline with ammonia, 
and again extracted with ether. The ethereal extract 
was then concentrated sufficiently to cause crystalliza­
tion of part of the alkaloid (ergotinine). The rest of 
the alkaloid was obtained in the amorphous state by 
adding petroleum ether.
Tanret*s process gives rise to troublesome emul­
sions and in order to avoid this difficulty various modi-
(1 22 )fications have been introduced. K e l l e r 1 first re­
moved the fatty oil with petroleum ether before extract­
ing the alkaloid with ether. K r a f t e x t r a c t e d  with 
ether, distilled off the solvent, and diluted the residual 
oily extract with 2 to 3 volumes of petroleum ether. The 
resulting precipitate consisted of alkaloids, yellow 
coloring principles and ergosterol. Kraft then treated 
the extract with ether and obtained the crude alkaloids 
by shaking the ethereal solution with 1/2 per cent 
tartaric acid solution.
G-ehe & C o . ^ * ^ ,  in a patented process, first ex­
tracted the drug with ether, distilled off the solvent, 
and then mixed the residue with an ethereal solution of
-60
a suitable organic acid (tartaric, citric, etc*) whereupon 
an alkaloidal precipitate results* Ibis precipitate was 
then treated according to the known methods of alkaloidal 
separation,
H e r o l d ^ * ^  proposed a method as follows: The drug
was slightly moistened, rendered alkaline, and extracted 
with benzene. The solution was first washed repeatedly with 
slightly alkalinized water and then with dilute citric or 
tartaric acid. The amorphous bases were precipitated by 
sodium hydroxide, care being taken not to exceed a pH of 7*7, 
The precipitate was filtered ■under reduced pressure, dis­
solved in ether, extracted with 1 per cent sulphanilic acid, 
and then reprecipitated with sodium carbonate. The product 
consisted, chiefly of ergotoxine and ergotinine.
When working on a large scale, however, the slight 
solubility of the chloride, and especially that of the bro­
mide, may be used to advantage. Barger and C a r r ^ 6  ̂ treated 
the residue, left on evaporation of the alcoholic solution, 
with petroleum ether to remove fatty matter, dissolved the 
alkaloidal residue in ethyl acetate, and shook with citric 
acid solution. Sodium bromide or hydrobromic acid was added 
and the precipitated hydrobromides collected. According to 
the above workers, a rough separation of ergotinine from 
ergotoxine was effected by repeated shaking of the solution 
of mixed hydrobrornides, in dilute sodium hydroxide, with 
ether. This removed the ergotinine which was finally cry-
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stallized from alcohol, The ergotoxine being more 
soluble in the alcohol than ergotinine, remained in 
solution.
In the extraction of ergotamine, Stoll^78  ̂ intro­
duced an unusual method of procedure. This consisted 
essentially in treating the drug with a solution of a 
weakly acidic substance such as aluminum sulphate, ferrous 
sulphate, ferric chloride or copper sulphate, and separa­
tion of extractive matter from the acid material by treat­
ment with a solvent such as benzene or ether. The alkaloid 
was then liberated by decomposition of its salt with an 
alkali, and then extracted with ether or benzene,
Stoll^78  ̂ laid stress on his ’’protective methods” of 
extraction and suggested that the failure of other inve­
stigators to obtain ergotamine may have been due to the 
use of ergots containing little or no ergotamine either 
because of age or deterioration, or because of poor ori­
ginal ergotamine content. He attributed the chief cause 
of the unsuccessful attempts at isolation of ergotamine to 
the use of insufficiently protective methods of extraction. 
Smith and Timrnis^79  ̂ tried to obtain ergotamine from a 
great variety of samples of official ergot, but were un­
successful. They examined three specimens of ergot grow-
(77)ing on festuca grass, hov/ever, and, using the Kraftv ' 
method, were successful in each attempt. As a result of 
this investigation they have suggested that the isolation
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of ergotamine and ergotaminine does not depend so much 
on the special methods of extraction which Stoll has 
stressed so much, but depends on the nature of the ergot.
Stoll has stated that he believes ergotaminine is 
only formed artificially by the chemical reagents used in 
some processes of extraction. This is supported somewhat 
by the fact that the use of strong alkalies in liberating 
ergotoxine from its crystalline salts leads to contamina­
tion with ergotinine and other impurities which prevent 
crystallization^^^ • According to Thompson(1^5) there is 
only one alkaloid in ergot which, depending on the method 
of extraction, may be isolated as ergotamine, ergotoxine 
or ergotinine. Indisputable proof, definitely showing that 
the alkaloid obtained is only a function of its method of 
extraction, as above, has hot yet been brought forward.
(i) A hew Constituent
(According to the clinical results obtained by Moirv 1 
there is reason to believe that the characteristic and tra­
ditional effect of ergot is due to a substance as yet uniden­
tified. Moir found that the effect of the drug comes on 
within four minutes of oral administration of the liquid 
extract (official in the 1914 edition of the British Phar­
macopoeia), and that the character of the powerful uterine 
contractions was notably different from those of ergotoxine 
and ergotamine: 11--they were frequent, regular, of fairly 
great excursion, and there was a rise in base line much 
greater than observed with any other drug/' The official
-63-
solid. extract and. even defatted ergot powder also shov̂ r 
great activity in stimulating contractions in the puer­
peral uterus• Moir states further: "--since histamine 
and tyramine were found to be inactive when given by 
mouth, either singly or in combination, it must be assLimed 
that the oxytocic power of the liquid and solid extracts 
is due to a substance whose importance has hitherto been 
overlooked in the investigation of ergot." As yet no 
published confirmation of Moir's observations has appeared.
H I .  EXPERIMENTAL
In order to carry out a general chemical analysis of 
ergot of rye, 50 pounds of the Spanish variety of drug was 
procured from S.B. Penick & Go* of New York City* The ergot 




Four additional samples of ergot of rye were 
obtained, from Prof. M.R. Thompson of this insti­
tution, so as to form a basis for comparison of 
results obtained from the total ash and from the 
results obtained by qualitative determination of 
the elements present in the ash. In the following 
tables sample A was taken from the fifty pound lot 
of drug.
SAMPLE OP TOTAL ASHGROUND DRUG T 1




T "  t
* 2.99$ *
t f
2.98$ ' 2.99$ ' | (
B ' 3.04$ '
f | 2.97 $ ' 3.01$ 'f |
C ' 3.03$ '
t | 3.07$ 1 3.05$ 1f |
D • 2.84$ 't | 2.82$ ' 2.83$ 'f |
E ' 2.89$ '
I I




Tiiis was determined only on the total ash of 





This was calculated by subtraction of the 
acid-insoluble ash from the total ash:
(1) (2)
2.963$ 2.957$
Qualitative Determination of Elements
For the purpose of this determination 100 grams 
of each unground sample was separately ashed and then 
extracted with boiling dilute hydrochloric acid. This
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acid solution was then tested according to routine 
qualitative analysis methods. The results are given 
in the following table:
ELEMENTS PRESENT
! A B C D E
' Fe Fe Fe Fe Fe
« A1 A1 A1 A1 A1
1 Mg Mg Mg Mg Mg
i Ivin Mn Mn —
* Na Na Na Na Na
» K K K K K
* Ga Ca -- __ Ca
i Cu — —
* Pb -- — — - -
TABLE X
Phosphorous was also found to be present in each 
of the above samples.
2. Preparation of Fluidextract
A fluidextract was prepared according to "Process C,r, 
United States Pharmacopoeia, Revision X, using a menstruum 
of dilute alcohol and 2 per cent hydrochloric acid. The 
drug was previously defatted with purified petroleum benzin,
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and "Process C" was used in the extraction because this 
process eliminates the necessity of applying heat for the 
concentration of the liquid extract to proper volume. This 
is in accord with the work of T h o m p s o n w h o  has shown 
that a more potent and a more representative preparation is 
obtained by extraction according to "Process C" rather than 
by "Process B" which the Tenth Revision of the United States 
Pharmacopoeia (Hereinafter, U.S.P.X), directs. The test 
for exhaustion applied to the percolate was one of those 
recommended by T h o m p s o n a s  follows:
"Approximately 4 cc. of this issuing percolate is 
diluted threefold with a saturated aqueous solution of 
sodium bicarbonate. Failure to develop precipitate tur­
bidity or faint opalescence during one hour shows that 
extraction is complete for practical purposes."
"Process C" was followed according to the directions 
given on page 160, U.S.P.X:
"Divide 1000 Gm. of the powdered drug into three portions 
of 500 Gm., 300 Gm., and 200 Gm., respectively. Moisten the 
first portion of the drug (500 Gm.) with a sufficient quan­
tity of the prescribed menstruum to render it evenly and 
distinctly damp and to so maintain it during maceration for 
six hours in a tightly-covered container. Then pack it in 
a cylindrical percolator, and add enough of the menstruum 
to saturate the powder and leave a stratum above it. When
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the liquid begins to drop from the percolator, close the 
lower orfice, and, having closely covered the percolator, 
macerate for forty-eight hours, and then allow the perco­
lation to proceed slowly, gradually adding more of the men­
struum. Reserve the first 200 cc. of percolate, and con­
tinue the process until additional percolate measures 1500 
cc., the latter being collected in successive portions of 
300 cc."
"Moisten the second portion of the powdered drug 
(300 Gm.) with a sufficient quantity of the percolate 
collected in the preceding operation, immediately after the 
reserved portion, to render it evely and distinctly damp and 
to so maintain it during maceration for six hours in a 
tightly-covered container. Then pack it in a cylindrical 
percolator, macerate, and percolate as directed for the 
first portion of the drug, using as menstruum, the several 
portions of percolate from the preceding operation in the 
order in which they were collected, and, if this is in­
sufficient, follow with more of the original menstruum. 
Reserve the first 300 cc. of percolate, and continue the 
process until the additional percolate measures 800 cc., 
the latter being collected in successive portions of 200 cc. 
each.
"Moisten the third portion of the powdered drug 
(200 Gm.), with a sufficient quantity of the percolate 
collected in the preceding operation, immediately after 
the reserved portion, to render it evenly and distinctly
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damp and to so maintain it during maceration for six 
hours in a tightly-covered container# Then pack it in 
a cylindrical percolator, macerate, and percolate as 
before, using as menstruum the several portions of per­
colate from the preceding operation in the order in which 
they were collected, and if this is insufficient, follow 
with more of the original menstruum# Collect 500 cc. of 
percolate, and mix this with the two portions previously 
reserved to make 1000 cc# of finished fluidextract*" 
a# Determination of Potency of Fluidextract
In the determination of potency a modification 
of the Broom-Clark biological method was used# This 
modification in technique has been published in detail 
by Thompson^6^  •
Each "reserved percolate" was tested separately by 
this biological method then mixed together and the mix­
ture assayed, thus affording a check on the value obtained 
for the final assay# The results were as follows:
Reserve percolate I: greater than 200$
Reserve percolate II: greater than 200$
Reserve percolate III: less than 175$
Average: 192$
Roughly, the resulting mixture of percolates shoiild 
show a potency around 190$# After mixing the portions, 
it was found that the potency of the preparation was 
175$ which may be accepted as a satisfactory agreement 
with respect to the assays.
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b. Fatty Oil
After extraction of the ground drug with petroleum
benzin, twenty per cent of fatty oil was obtained. The
oil was light amber in color and had no appreciable odor.
It was turned over to Mr. G. E. Cwalina for investigation,
3. Extraction of Alkaloids from Crude Drug
a. According to Stoll Method
Stoll used the following method(^9) for the extraction
of ergotamine and ergotaminine from the crude drug:
Two kilos of ergot were ground to grains of about the
size of one cubic millimeter and thoroughly mixed with a
solution of 60 Gm. of crystallised oxalic acid in half a
liter of lukewarm water, the grinding being then resumed
until the moist substance was reduced to a high degree of
fineness, after which the drug was introduced into 5 liters
of ether. After being allowed to stand for several hours
with occasional stirring, the deep-orange colored liquid
containing the principal part of the fatty oils and other
neutral and acid constituents, was separated by suction
and the residue was washed for another two hours with
3 or 4 liters of ether, in portions of half a liter at
the time, further removal of fatty constituents being
afterwards accomplished by percolation with 4 liters of
ether. After a short suction of the ether from the fine,
wasnow more clear drug dust, the latter/again suspended in 
ether to which about 5 per cent ethyl alcohol had been
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added, and to this a cooled solution of 200 to 220 
Gm. of cyrstallized barium hydroxide in 3/4 liter of 
water was gradually added, the liquid and suspended 
matter being energetically agitated the while. The 
resulting solution gave a weakly alkaline reaction in 
which there was no free alkali liable to destroy the 
desired alkaloids. After two hours, the light yellowish 
extract in ether was separated by filtering under reduced 
pressure. With a good grade of ergot, Keller!s iron 
chloride test, applied to one cc* of the filtrate gave 
an intense reaction. This reaction became gradually 
weaker after the drug had been washed with about 4 liters 
of the solvent, which was allowed to percolate slov/ly 
through the cellular tissue, under reduced pressure, for 
two or three hours, in portions of half a liter at a 
time. Finally, the reaction could only be observed 
plainly with large volumes of filtrate.
The extract of alkaloids in ether was concentrated 
at once to 1/2 to 3/4 liter by evaporation, and the con­
centrated liquid was decanted, leaving behind a residue 
which contained no alkaloids* The liquid obtained by 
this separation was evaporated to dryness in vacuo below 
30°C. For the separation of further traces of fatty 
substances, and of phytosterols, the liquid yellow resi­
due was treated with half a liter of petroleum ether, 
and, after filtering, the residue of crude alkaloids, 
dried in vacuum,was dissolved in ether. This produced
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a light yellow solution which was concentrated to about 
3/4 liter by evaporation, after which the base separated 
in groups of white crystals# The crystals obtained in the 
last stages of the crystallization, when the mother liquor 
was reduced by evaporation to a very small volume, consisted 
of yellowish globules containing only from 9-1/2 to 10 per 
cent of nitrogen, but by recrystallising these with ether, 
they could be transformed into white particles containing 
also 1 1-1/2 to 12 per cent of nitrogen as in those crystals 
first obtained#
The method of Stoll, essentially as stated above, was 
applied in the attempted isolation of ergotamine and ergo- 
taminine on 3 occasions, but in neither case was the attempt 
successful when applied to this sample of drug (lot #A, 
obtained from S.B. Penick & Co#, New York City). As a result 
it was concluded that the drug originally contained very 
little, if any, of these alkaloids,
b. Extraction according to the Kraft Method
Three kilos of drug, Lot A, were then extracted as 
follows: The ergot powder was placed in a large flask and
to it was added 800 cc. of water and 4-1/2 kilos of ether.
This was shaken together for 1 hour, after which the ethereal 
liquid was filtered off and set aside. The remaining dampened 
powder was then treated ten times with 2-1/2 kilogram, por­
tions of ether (without addition of water) in the same manner 
as above. The 4-1/2 kilogram portion of extractive was left
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untouched for the time being, but the succeeding portions 
were mixed and concentrated by distillation to the same 
weight as the first extract* All of the ethereal extracts 
were then combined and shaken out with portions of 1/2 to 
1/4 liter of one-half per cent tartaric acid solution*
The clear filtered shakings were then treated with powdered 
sodium bicarbonate until the liquid was alkaline to litmus* 
The precipitated alkaloids were gathered on a suction-fliter, 
washed, and dried over sulphuric acid* About four grams 
of crude alkaloids were obtained*
(1) Extraction of Ergotoxine
These alkaloids were separated by means of their 
sulphates according to the following method of Kraft 
One part of dry crude alkaloid was dissolved without 
heat in three parts of glacial acetic acid and the 
solution diluted to 300 parts with water. The turbi­
dity of the solution was removed by filtration, with 
the aid of a knifepoint of kieselguhr, on a suction 
filter* The filter was then washed with water until 
the filtrate measured 400 parts and this was treated 
with a filtered solution of one part of anhydrous sodium 
sulphate in 100 parts of water whereupon ergotoxine sul­
phate separated, while ergotinine sulphate remained in 
solution. After standing about two hours the precipi­
tate was sharply sucked off. The damp sulphate was 
again stirred with water, ether abundantly added, and
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the whole was shaken with the amount of sodium bicar­
bonate necessary to render the liquid alkaline to litmus, 
until the liberated alkaloid was dissolved in the ether•
The ethereal solution was separated and dehydrated with 
anhydrous sodium sulphate# The ether was evaporated in 
vacuo and in this manner the amorphous ergotoxine was 
obtained# It was crystallized from hot benzene in accordance 
with the process of the Wellcome Foundation^116  ̂ wherein 
only weak alkalies such as sodium bicarbonate or borax are 
used in obtaining the base previous to its crystallization 
from benzene. Only a very small yield was obtained# The 
crystals softened at about 179° and melted indefinitely 
between 190 and 200°#
(2) Extraction of Ergotinine
The ergotinine sulphate present in the filtrate, 
obtained after precipitation of the ergotoxine sulphate, 
was precipitated with sodium bicarbonate, the alkaloid 
filtered by suction, washed, and dried over sulphuric acid. 
The alkaloid was crystallized from hot 70 per cent alcohol# 
The crystals obtained melted at 219°•
For this purpose ten kilos of powdered ergot were treated 
according to the method of S t o l l i n  an effort to learn 
whether any ergotamine or ergotaminine was present in ohe drug 
in small quantity. The attempted isolation in this case, how­
ever, was not carried out quickly enough because the alkaloids
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known to have been present (ergotoxine and ergotinine) had 
decomposed, as indicated by negative Keller iron chloride 
tests, before the completion of the isolation process.
4. Isolation of Ergochrysin
This substance was obtained by the method of Kraft^*^, 
that is, by extracting the defatted marc of the drug after 
extraction of its alkaloids by ether, with chloroform. The 
chloroform was distilled off under reduced pressure on a 
water bath and the residue then treated with petroleum benzin 
until a dry yellowish powder was obtained. This was rubbed 
to a thin consistency with glacial acetic acid and filtered 
and washed with small amounts of glacial acetic acid on the 
suction-filter. After this treatment, lemon-yellow needles 
of ergochrysin remained on the filter and were allowed to dry.
The crystals were treated with boiling methyl alcohol to fur­
ther separate any fatty material (ergosterin) and were cry-
ostallized sever8.1 times from chloroform. M.P. 244 •
5. Analysis of Hydro-alcoholic Extract
a. Alkaloidal Potency of nFluidextractn
The marc left after extraction of the ten kilos of 
ergot with ether according to the Stoll process was tested 
for alkaloidal activity through the medium of a ’'fluidextract" 
prepared from a sample of the above marc by the U.S.P.X 
"Process Cu• This fluidextract was tested as follows:
(1) Van Urke-Smith color reaction^45^. Result:
Weakly positive.
(2) Cock*s Comb Method of the U.S.P.X. Result:
PLATE I
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Potency considerably below 25 per cent*
(3) Broom-Clark Method using the Thompson technique(64)  ̂
Result: Alkaloidal activity of less than 5 per cent
(See plate I)* 
b* Activity of 25 per cent Alcoholic Extract
An aqueous-alcoholic extract was prepared from the 
marc left after the large scale extraction* This extract 
was tested for the type of activity found by M o i r ^ ^ *
The experiment was carried out on virgin guinea pig 
uteri in the same manner as Pituitary Solution is assayed 
in the U.S*P*X* The type of reaction obtained seemed to 
be characteristic of histamine* 
c* Treatment with Lloyd*s Reagent
This experiment was carried out to ascertain the 
effect of treatment with Lloyd*s reagent (hydrous aluminum 
silicate) as follows: One hundred cubic centimeters of the 
25 per cent alcoholic extract was mixed with 5 cc* of dilute 
sulphuric acid and with 2 Grn* of Lloyd*s reagent and the 
mixture agitated for 30 minutes* After the suspension had 
settled it was filtered*
(1) Comparative Studies
(a) On Guinea Pig Uterus
The filtrate was then tested on the uteri 
of virgin guinea pigs as before treatment of the 
extract with Lloyd*s reagent*(See plate III).
This tracing shows that 0*25 cc* of the original 
solution (H) was equivalent to 0*3 cc* of the
H *  p i t u i t a r y  S d / i -  M o . o o o
V V =  W a s h
H - i - G
■ .ft nfr • m  all
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h i m  •M i
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standard pituitary solution (P), and that 0,5 cc, of 
the filtrate (J) was equivalent to 0,25 cc, of "H". 
or, 0,5 cc, of J ** 0,25 cc. of H 
therefore,0.5 cc. J n 0.3 cc. P 
In other words, one-half the activity of the original 
aqueous extract was removed by the tres-tment with Lloyd Ts 
reagent.
(b) On Blood Pressure
In order to preclude the possibility of the presence 
of the Moir principle in the extract, the liquids H and J 
were tested, by the usual blood pressure method, on a dog. 
(This experiment was necessary because histamine gives the 
same type of activity on the isolated uterine muscle of the 
guinea pig as does the Moir principle). The tracing is 
shown on plate IV.
In this experiment, the last four doses (0.4 cc. H,
0.2 cc. S, 1 cc. J, 1 cc. J), showing on a moving kymograph, 
the fall and prompt recovery from depressor effect removed 
all doubt that the constituent responsible for the activity 
in the 2 unknown solutions was histamine, or a body anala- 
gous to histamine in its action.
Thus the principle partly extracted by Lloyd1s reagent, 
and responsible for the activity shown on the guinea pig 
uterus, was histamine or a body analagous to histamine in 
its action, and the principle showing an activity similar 
in nature to that activity clinically described by Moir^23  ̂
was apparently absent from these extracts.
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It is believed that any clinically active substance 
such as described by Moir must necessarily be absent 
because of* the fact that the extracts possessed no activity 
sufficiently persistent to be clinically significant. This 
point has been studied extensively by T h o m p s o n ( l 2 7 )  and he 
has concluded that the activity, as measured in plate IV, 
is of a histamine-like character and exerts no significant 
uterine activity on the intact pregnant, non-pregnant or 
puerperal animal.
After the elapse of one year, liquid H was tested for 
amine activity in the laboratory of Professor M.R.Thompson 
by Mr.C. T.Ichniowski, using the blood pressure method.
It was found, on assaying the amine content in terms of 
histamine, that the liquid extract contained less than
0.0025 mg. of amines per 0.15 cc.
As a result of this report no attempt was made to 
isolate amines from the extract because only an insignifi­
cant quantity of the substances appeared to be present, 
d. Identification of Potassium and Magnesium Phosphates
Fifty cc. of the 25 per cent alcoholic extract was 
treated with 150 cc. of 95 per cent alcohol which resulted 
in the production of a fine precipitate. This was allowed to 
stand several Jipurs, at the end of which a crystalline deposit 
was found. After treatment with charcoal and recrystalliza­
tion, the phosphates were identified as follows:
(1) Potassium dihydrogen phosphate
By means of the flame test potassium was identified.
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The phosphate radical was identified when on the addition 
of nitric acid and ammonium molybdate solution, a yellow 
precipitate resulted which was soluble in sodium hydroxide 
solution. The compound was identified as the dihydrogen 
phosphate through its solubility: Soluble in cold and hot 
water but insoluble in alkalies.
(2) Magnesium phosphate
This substance was identified when on the evaporation 
of its aqueous solution to about 2 cc*, addition of ammo­
nium chloride solution, addition of ammonium hydroxide 
until basic, and the addition of sodium dihydrogen phos­
phate solution, a white precipitate was produced as soon 
as the walls of the test tube were scratched with a glass 
rod. This precipitate indicated magnesium and since the 
phosphate radical was the only one found, the compound 
must have been a magnesium phosphate* 
e« Identification of Glucose
The glycoside, Glavicepsin, reported as being a consti­
tuent in ergot by Marino-Zuco and P a s q u e r o ^ ^  was not expected 
to be present, as such, in this hydro-alcoholic extract* It 
was felt that Clavicepsin could not be present because at this 
time the extract was over a year old and was definitely acid 
to litmus. Since the glycoside is easily hydrolyzed by boil­
ing with mineral acid(^), it was thus thought that, although 
there had been no boiling, the length of time during which 
the Clavicepsin had stood in contact with the acid had provi­
ded for its hydrolysis* This view was supported by the fact
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that the original extract already showing reducing pro­
perties towards Fehlingis solution, did not show any 
appreciable increase in the degree of reducing power 
exhibited after heating with mineral acid. Consequently 
no attempt was made to isolate Clavicepsin from this 
extract. Instead, it was decided to try to isolate glucose 
as the phenyl osazone. The method employed was the usual 
method of procedure. Twenty cc. of extract was treated 
with 2 Gm# of a mixture consisting of 1 part phenyl hydra­
zine hydrochloride to 2 parts of sodium acetate. The test 
tube was placed in a boiling water bath and allowed to stand 
for 30 minutes. A yellow osazone was obtained and was re- 
crystallised from boiling 60 per cent alcohol, M.P. 205°. 
Since it was observed that no white hydrazone was formed 
during the process of reaction, the possibility of the osa­
zone having been formed from mannose was eliminated. The 
melting point and shape of the crystals viev/ed under the 
microscope limited the possibility to levulose and glucose 
as being the source of the osazone. In order to decide 
between the two, a Seliwanoff test for ketoses was run on 
the original extract. This reaction consists in the deve­
lopment of a deep red color followed by the appearance of 
a precipitate when a ketose, such as levulose, is heated 
with strong hydrochloric acid and resorcinol. The test was 
run as follows: Ten cc. of the reagent (0.5 Gm. resorcinol
in 100 cc. hydrochloric acid diluted to 300 cc. with water)
80-
was placed in a test tube and 2 cc* of the solution to
be tested was added and immersed in boiling water* If
a ketose is present, the solution will quickly turn red 
and a reddish precipitate will appear.
Three tests were prepared as follows:
1* Ten cc* of reagent and 2 cc* M/5 glucose + 2 cc. extract
produced a negative result (no red)•
2* Ten cc* of reagent + 2 cc* M/5 levulose + 2 cc* extract
produced a red color and precipitate.
3. Ten cc. of reagent + 2 cc* extract produced no red.
Thus it is seen that the original extract must have
contained glucose.
£• General Analysis
This was conducted on the 25 per cent alcoholic extract 
essentially according to the lead method outlined in Rosen- 
thaler T s ̂ -^8) ? ,rfhe Chemical Investigation of Plants”. After 
heating 2-1/2 liters of the extract to boiling it was mixed 
with a saturated solution of lead acetate in slight excess.
The lead precipitate (A) obtained, was washed by decantation, 
first with saturated lead acetate solution, and then with 
water until the washings were no longer acid to litmus. The 
filtrate, including the washings, concentrated by evaporation, 
was precipitated with basic lead acetate solution and washed 
Y/ith first this solution and then water, as above. The preci­
pitate (B ) was separated from liquid B in the same way as 
precipitate A from liquid A.
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Precipitate A was then refluxed with 95 per cent 
alcohol for several hours, hut only a negligible amount 
of extractive was obtained in this manner,
The residual precipitate A was then treated with ten
per cent acetic acid. In order to ascertain the amount of 
material extracted by the 10 per cent acetic acid, basic 
lead acetate solution was added to some of the liquid.ex- 
tract.Ihe absence of a precipitate, resulting on the addi­
tion of the basic lead acetate solution, indicated that 
practically no material had been extracted. The solution 
was then neutralized with sodium carbonate solution and 
then shaken with chloroform. No extractive was contained 
in the chloroform, as shown on evaporation. Ether likewise 
failed to extract anything from the neutral solution. Sihce
it was thus shown that the original acetic acid extraction
must have contained very little extractive matter, work on 
it was stopped.
The portion of precipitate A not dissolved by alcohol 
and acetic acid was suspended in water and decomposed with 
hydrogen sulphide. The lead sulphide was filtered off and 
set aside for investigation. The filtrate was treated as 
follows: A stream of carbon dioxide gas was passed through
the liquid to remove the excess hydrogen sulphide. The 
liquid had a dark yellow color and pyroligneous odor.
A test for tannins with ferric chloride solution was nega­
tive as was also a test for carbohydrates by the alpha- 
naphthol reaction.
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The dark ye H o w  liquid was shaken several times 
with ether and with chloroform* On concentrating the 
ether shakings, a small quantity of white needle-like 
crystals separated* The amount obtained, however, was 
too small for identification purposes. The chloroform 
extraction yielded nothing.
The yellow liquid was finally concentrated on a 
water bath and a small amount of dark syrupy residue 
remained*
The lead sulphide precipitate was next examined in 
order to see if it had carried down any substance with it 
on precipitation* The black precipitate was treated as 
follows:
The precipitate was extracted with portions of boiling 
water which yielded liquids similar in color and. odor to 
the one obtained above. These liquid extracts were much 
darker at the beginning of the extraction than at the end* 
They were concentrated separately on a water bath, and in 
a beaker containing some of the lighter colored liquid, 
after its concentration, a minute quantity of whitish powdery 
substance was noted.
(1) Identification of Sulphur
The part of the lead sulphide precipitate not dis­
solved by the boiling water was next extracted with 
boiling alcohol. On allowing the hot solution to cool, 
after filtering, needle-like yellow crystals appeared.
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These crystals were recrystallized from both alcohol 
and chloroform. They melted on ignition and at first, 
due to the present of inpurity, they appeared to be 
organic in nature. After repeated recrystallization, 
however, it was seen that the crystals were inorganic.
They melted at 119° and could be sublimed* They were 
soluble in chloroform and in hot 90 per cent alcohol; 
they were insoluble in water and cold alkalies* Prom 
these properties the substance was identified as mono­
clinic sulphur, present probably as a result of the use 
of hydrogen sulphide during the course of this procedure.
(2) Isolation of Mannitol
The precipitate (B ), obtained by adding saturated 
solution of lead subacetate to the filtrate from (A), 
was divided into 2 parts. One part was extracted with 
boiling alcohol, but this procedure failed to extract any 
appreciable amount of material from the lead precipitate. 
The 2 parts of the lead precipitate were then combined, 
suspended in water, warmed on a water bath, and decomposed 
by introduction of hydrogen sulphide. The filtrate was 
evaporated to syrupy consistency under reduced pressure 
and then precipitated with alcohol. The precipitate was 
washed with alcohol and dried over sulphuric acid. The 
dry precipitate was then extracted by boiling with alcohol 
which on cooling gave rise to a white crystalline precipi­
tate. This was purified by repeated solution in water and 
fractional precipitation. It was finally crystallized
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from water* M*P* 166°* Since the above was essentially 
the process used by Kraft in obtaining mannitol from 
erogt, the substance herein obtaihed was thought to be 
mannitol also. The addition of some mannitol to the 
white crystals did not lower the above melting point, 
consequently the crystalline substance was concluded to 
be pure mannitol*
The filtrate (B) obtained on separation of preci­
pitate (B) was treated with hydrogen stilphide to decom­
pose the lead subacetate present and filtered to remove 
the resulting lead sulphide precipitate* The filtrate, 
after being treated with carbon dioxide to expel the 
hydrogen sulphide, was divided into 3 parts. Part one 
was concentrated to syrupy consistency on a water bath.
This syrup on being seeded with crystalline trehalose 
and after prolonged standing, failed to yield any treha­
lose. Since this was essentially Mitscherlich* s 
procedure in obtaining trehalose, it was concluded that 
the disaccharide, if originally present in the extract, 
had been hydrolyzed into its component molecules of glucose. 
Part two of liquid (3) was concentrated on a water bath and 
allowed to evaporate in vacuo over stilphuric acid.
The resulting mass remains to be investigated as do 
also part three of liquid (B) and the various lead sulphide 
precipitates obtained during the course of the procedure.
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SUMMARY AND CONCLUSIONS
1. The total ash of the samples of drug examined varied from 
2*85 per cent to 5*01 per cent*
2. The elements found to he present in the ash were: Iron, 
aluminum, magnesium, manganese, sodium, potassium, calcium, 
copper, lead, and phosphorous*
3* A sample of ergot, sample A, was found to have an alkaloidal 
potency of 175 per cent.
Three attempts to isolate ergotamine from this lot of 
drug, using a process essentially that of Stoll, were un­
successful. It was, therefore, concluded that this drug 
originally contained little, if any, ergotamine.
4. Ergotoxine and ergotinine were obtained from lot A by means 
of the Kraft process.
5. Ergochrysin was obtained, by the Kraft process, from sample A.
6. A "fluidextract" prepared from the marc of a drug extracted 
with ether, showed an alkaloidal potency of less than 5 per 
cent.
7. On the basis of comparative studies made on uterine muscle 
and on blood pressure, it was found that about 50 per cent
of a substance believed to be either histamine or a substance 
exhibiting an activity similar in nature to that of histamine, 
was extracted from a hydro-alcoholic solution by means of 
Lloyd*s reagent.
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8, The principle showing an activity of the type described 
by Moir was apparently ahsent from these extracts* It 
was concluded that any clinically active substance, such 
as described by Moir, must necessarily be absent because 
of the fact that the extracts possessed no activity suf­
ficiently persistent to be clinically significant*
9* A precipitate, consisting partly of crystalline potassium 
dihydrogen phosphate and a magnesium phosphate, was obtained 
on addition of 3 volumes of 95 per cent alcohol to a 25 per 
cent alcoholic extract.
10. The acidity of an extract of this type (e.g. 25 per cent 
alcoholic extract) together with the time factor involved, 
resulted in the production of glucose through hydrolysis 
of either Clavicepsin or Trehalose, or both.
11. Crystals of sulphur were obtained during an analytical 
procedure which involved the use of hydrogen sulphide.
12. A substance believed to be mannitol was obtained from a




Since completion of this paper, a new alkaloid, 
ergoclavine, has been reported. At present, however, 
only a brief description is available since the complete 
report has not been published.
Ktissner(*^9) obtained ergoclavine in the following 
manner: The total alkaloids were extracted from solution
in benzene or ether, by means of very dilute acid. By 
making alkaline with sodium hydroxide solution, the greater 
part of the ergotinine present, was obtained. After acidi­
fying the alkaline liquid, ergotoxine was separated by 
renewed shaking with ether. By subsequent extraction of 
the liquid, made alkaline with soda, with trichlorethylene, 
a hitherto unknown alkaloid was obtained (ergoclavine),
Ergoclavine has the following properties: It crystal­
lizes from 90% alcohol; after drying at about 20° and 30 mm. 
pressure, over phosphorous pentoxide, it has a melting point 
of 170-171° and an optical rotation in chloroform (1%) of 
4*115°• This alkaloid, after drying as described, lost 
weight after heating for several hours at 80° and at a 
pressure of from 1 to 2 mm. The completely water-free or 
solvent-free, very hygroscopic substance melted at 177 to
o f "7 22178 , s *.124° (1 % in chloroform). Incomplete
D
analytical determinations, as reported by Kttssner, have 
indicated the formula of the alkaloid to be C^HjjgNgC^.
-86-B
According to Kreitmar^129) the pharmacologic activity both 
qualitatively and quantitatively was the same as that of 
ergotoxine•
The above constants of ergoclavine bear a resemblance 
to none of the previously discussed ergot alkaloids, but 
they do strikingly resemble those constants reported for 
the so-called nnew alkaloid” sensibamine (found by Stoll 
to be impure ergotamine(130)) j_n British Patent No.388,529 
of Chinoin A.G-. and Wolf. The difference between ergocla­
vine and sensibamine, as given by Kiissner, was that the 
solubility of the former remained constant in solvents 
such as methyl and ethyl alcohols, acetone, and ethyl ether. 
When sensibamine was dissolved in any of these solvents, 
however, there was rapid transformation of the alkaloid 
into a substance insoluble in the solvent used.
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